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ABSTRACT 
Facilitatory and depolarizing drugs both produce facili~tion of the 
cat skeletal muscle, and antidromic firing in the motor nerve following an 
orthodromic stimulus. 
Drugs were administered i. v. or close-ar-::e:c1ally to the anterior 
tibialis muscle of the cat, and gross motor nerve potentials were 
recorded from the ventral root. Antidromic firing following an 
orthodromic stimulus was asynchronous in the presence of facilitatory 
drugs and a mixture of synchronous and asynchronous firing in the 
presence of depolarizing drugs. The dep.:>larizing drugs and neostigmine, 
edrophonium and ambenonium also produced antidromic firing in the 
. absence of nerve stimulation. Methoxyamb(monium augments the 
antidromic firing of the depolarizing drugs following an orthodromic 
stimulus butprevented that in the absence of nerve stimulation. 
Hemicholinium and triethylcholine prevent the antidromic firing produced 
by both facilitatory and depolarizing drugs. Tubocurarine also prevented 
the antidromic firing by both types of drugs. 
The results are explained on the basis of two cholinoceptive sites 
on the motor nerve terminal, one at the first node and one on the 
unmyelinated terminal. 
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INTRODUCTION 
There is now some agreement that facilitatory drugs have an action 
at the motor nerve terminal in mammalian muscle (for refe/ences see 
Werner and Kuperman, 1963; Karczmar, 1967). However, the sites and 
mechanism of action have yet to be elucidated. 
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Masland and Wigton (1940) concluded that neostigmine inhibited 
cholinesterase and allowed acetylcholine to depolarize the motor nerve 
terminal. This mechanism of action was restated by Eccles ( 1964). Riker 
and his co-workers ( 1957, 1959) and Blaber and Bowman (1963 a &b) 
concluded that various hydroxyaniliniums (including neostigmine) and 
oxamides had a direct action on the terminal producing facilitation which 
was not mediated by acetylcholine. Furthermore, Hubbard, S:hmidt and 
Yokota (1965) have concluded that neostigmine has two actions at the 
terminal, one to depolarize the first node and the other to produce 
antidromic firing in response to an orthodromic stimulus. 
The object of the present experiments was to determine whether 
facilitatory drugs produce their action by a direct depolarizing action 
at the motor nerve terminal, by a depolarizing action mediated by 
acetylcholine or by some other action. To achieve this, facilitating drugs 
have been compared with depolarizing drugs in their a~tions on the motor 
nerve terminal. 
A short account of the anatomy and physiology of the neuromuscular 
/ june tion precedes a more complete review of the present state of the 
problem. 
9 
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I. ANATOMY 
The study of the structure of the neuromuscular juncti<in. is of 
considerable interest, for only in the last decade has it been possible, 
with the use of the electron microscope, to find new elements of structure 
which begin to provide a morphologic basis for the understanding of the 
transmission process (Figure 1}. 
The terminal motor axon loses its myelin sheath close to its 
-branching, the branches making a series of contacts with the motor end-
plate. Each fiber ends in a synaptic gutter (a depression in the muscle 
surface that accommodates the axon terminal (Robertson, 1956). The 
terminal is surrounded ·by thin projections of S::hwann cell cytoplasm that 
extends over the synaptic cleft (''primary cleft!'). The axon terminal and 
muscle fibers are separated by continuous membranes (Couteaux, 1960} 
and the muscle plasma membrane is thrown into a series of deep 
infoldings {"secondary clefts"), some of which are branched or 
anastomose with the neighboring infoldings. These "junctional folds" 
(C outeaux, 1944), {"subneural apparatus", C outeaux, 194 7} run at right 
angles and parallel to the fiber axis and communicate with the ·.external 
space at both sides of the nerve terminal which they surround. 
A moderately dense homogeneous material occurs in both the 
primary and secondary synaptic clefts (Barrnett, 1962; De Robertis, 1964}. 
1 
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The pre- and postsynaptic membranes show specialization consisting of 
patches of high electron density called "active points" (Coutefux, 1961). 
The axolemma follows at a 1000 A 0 interval the general outline 
of the junctional trough without penetrating the subneural infoldings. 
Two organelles characterize the axoplasm: mitochrondria and vesicles. 
The terminal axonal branches have a much denser mitochondrial content 
than the axon (Eccles, 1964). 
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In the motor· nerve terminals the vesicles are grouped in clusters 
near, or directly upon that part of the presynaptic terminal that fronts the 
synaptic cleft (Birks, Huxley and Katz, 1960). The vesicles are postulated 
to flow toward the axonic terminal mem".Jrane:·and discharge the chemical 
mediator into the intermembranal cleft. 
~naptic vesicles are hollow spherical elements of about 500 A 0 
in diameter, and by chemical methods it can be shown that the transmitter 
acetylcholine is concentrated in the subfraction containing the synaptic 
vesicles (DeRobertis, Pellegrino de Iraldi, Rodrigues de Lores Arnaiz, 
and fulganicoff, 1962; DeRobertis, Rodrigues deLores Arnaiz, 
fulganic off, Pellegrino de Iraldi, and Zieber, 1963}. De Robertis et. al. 
(1963} has shown the presence of choline acetylase in the synaptic vesicles; 
however, the:!."•;! i.o:1 some controversy about this. Fonnu.m {1966) claims 
tne lnembra:n.t:-botmd cholin·::: acetylase is an artefact due to the low iomc 
strength and low pH of dilute water suspensions of synaptosomes used by 
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the De Robertis group. The unifonn size of the vesicles corresponds with 
the uniformity that is indicated for the packets of transmittey responsiqle 
for the miniature end-plate potentials (m. e. p. p. 's), and for the failure 
to modify the size of these packets by experimental means (Del Castillo and 
Katz, 1956) .. The packets have the same size for muscle of very different 
diameters. Due to different input resistances them. e. p. p. 's are more than 
ten times larger in the smaller fibers than in the larger (Katz and Thesleff, 
1957). The quantalliberations occur at a multitude of foci distributed over 
the whole area of the synaptic contact (Del Castillo and Katz, 1956) which 
also corresponds with the distribution of vesicles. 
Recently, Birks (I 966) revealed more in regard to the vesicular struc-
tures contained in the nerve terminal. After fixation of frog axon in 
acrolein, Birks saw large diameter tubules that were long and winding, 
sometimes branched, and that tended to lie with their long axes at right 
angles to the long axis of the nerve with one end often in contact with the 
axolemma in the region where it made synaptic contact with the sarcolemma. 
Occasionally, the lumina of the tubules appeared to open into the synaptic 
space, that is, the space between axolemma and sarcolemma. 
Birks was able to show uptake of thorium dioxide particles by 
synaptic vesicles and both small and large diameter tubules. These 
particles penetrated the axon-Schwann space when the concentration was 
high, but penetrated the synaptic space at both high and low concentrations. 
1111""'"' 
Because of the location of large and small diameter tubules in the nerve 
/ 
endings Birk::: 3uggested that the large diameter tubules and vesicles 
take up the particles from the synaptic space and the small tubules take 
up the particles from the axon-S:hwann space. Birks proposed that the 
vesicles open momentarily through the axolemma, discharge their 
acetylcholine and pick up py pinocytosis, or a combination of pinocytosis 
and specific binding, ,the choline fragment;after hydrolysis of the 
liberated ester for resynthesis into acetylcholine in the nerve endings. 
The possibility of storage of acetylcholine in the synaptic tubules is also 
14 
an attractive concept from Birks' work. These tubules have been observed 
elsewhere; Barr-:1ett ( 1962), using rat diaphragm occasionally noticed 
elongated profiles of membrane-bounded tubules having the same 
diameter as the ~esicles (200-400 A 0 ) occurring adjacent to the populations 
of vesicles. Several functional problems can be formulated with regard to 
the vesicles, though, as yet, none are satisfactorily answered: the mode 
of production of the vesicles; the control of their movement up to the 
synaptic cleft; and their sul:aequent fate after extrusion of contents. 
15 
II. PHYS:OLOGY 
-------
A. Membrane theorr / 
It has been known for nearly a century that small electric currents 
propagate nerve impulses along axons. All modern concepts as to the 
mechanism of conduction are still based on the so-called membrane theory. 
According to this theory, the nerve fiber is surrounded by a semi-
permeable membrane which has a positive charge on the outside and a 
negative one on the inside. When a stimulus reaches a membrane, the 
permeability at the ac~ve site is greatly increased for all ions with a 
concomitant decrease in resistance. The active part becomes depolarized; 
thereby, small electric currents are gener~ted which stimulate the 
adjacent poit_1ts, and the same process takes place there. In this way, 
-
successive parts of the membrane are activated and the impulse is 
propagated along the axon. Only one modification has become necessary 
in the last century. At the activated point there is not just a simple 
neutralization but a reversal of polarity; the inside becomes p:.>sitive and 
the outside negative (Curtis and Cole, 1942). During the pas sage of the 
impulse the charge does not just disappear, as was assumed originally, 
but is reversed. 
In o:t!de1· t"' e·~nL=d.n the reversal of membrane potential during the 
impulse it is assumed that at the crest of the spike the membrane is 
selectively permeable to the sodium ion. The assumption is supported 
/ 
by the observation that the action potential of many excitable tissues 
fails in the absence of external sodium. Propagation is brought about 
by the flow of c•~rrent between resting and active nerve. The current 
reduces the membrane potential just ahead of the active region by 
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drawing charge out of the membrane capacity. As a result of the decrease 
in membrane potential the permeability to sodium rises and sodium ions ent 
making the inside of the fiber electrically positive. In this way a wave of 
internal positivity and of increased sodium per:meability spreads along the 
nerve fiber. The propagating agent is the electric current which is 
generated by the change in permeability. The rise in sodium permeability 
is short-lived, and potassium permeability increases during the latter 
part of the action potential. The effect of these changes is that after a 
short period (0. 3 msec.) potassium ions leave the fiber faster than sodium 
ions enter. The outward migration of potassium ions restores the 
original potential difference across the membrane capacity, and after a 
brief period the fiber is once more in a condition in which it can again 
conduct an impulse. 
The motor nerve to the anterior tibialis muscle consists of fibers 
1-20 microns in diameter. An impulse travels in this type of fiber at a 
speed of 5-120 metP.rs per second with a spike duration, including the 
absolute and relative refractory periods in the order of 0. 4-0. 5 milli-
/ 
seconds. The negative after potential ranges from 12-20 milliseconds and 
represents 3-So/o of the spike height. The positive after potential is 40-60 
milliseconds in duration and represents approximately 0. 2o/o of the spike 
height (Gasser, 1941). The nerve divides approximately seven times and 
innervates in the order of 120 muscle fibers comprising a motor unit 
(Sherrington, 1925; Clark, 1931). The units are not com pact but are spread 
throughout the entire muscle. In most mammalian muscles there is a one 
to one ratio between nerve branches and muscle fibers; that is, each 
muscle fiber is innervated by· only one nerve branch. The tibialis anterior 
muscle of the cat has been used for the experiments disc us sed in this 
thesis and consists of such focally innervated muscle fibers. At the 
terminal the axon loses its myelinated sheath {Wagner, 184 7). Hubbard 
and Schmidt {1961) have shown that in the motor nerve terminal the time 
course of the action potential is 1. 3-3 milliseconds, the negative after 
potential is 15-30 milliseconds, and the positive after potential is 50 
milliseconds, although these may prove to be the properties of the action 
potential at the first node {see Hubbard, Schmidt and Yokota, 196 5) and 
closely resemble the properties of the main axon. The theory that the 
nerve terminal is passively depolarized by electrotonic spread 
(Eccles, 1964) has been disproved (Katz and Miledi, 1965 a, b), and 
acetylcholine release from the terminal is related to active pfopagation. 
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As recorded ex:tracellularly, values of synaptic delay for the 
neuromuscular junctions of mammals and amphibia respectively are in the 
order of 0. 5 and 0. 6 msec. (Eccles, Katz and Kuffler, 1941). ·Recently, 
Katz and Miledi (19S5 a & b) have applied the method of recording "focal" 
potential changes in the frog nerve sartorius preparation to the measure-
ment of synaptic delay. At 20°C the synaptic delay had a minimal 
duration of 0.4-0. 5 msec. and a modal value of 0. 75 msec. Hubbard and 
S:hmidt (1963) have reported a value of 0. 22 msec. for a single neuro-
muscular synapse of the isolated rat diaphr.agm which makes it the 
briefest yet :l:"eported. 
£:.__;'\_s~lc holine 
It is now generally accepted that acetylcholine is responsible for 
the transmission of the excitation from the nerve endings to the motor 
end-plate. The classical work of Brown, Dale, Feldberg, and many 
others clearly established by the late 1930's the role acetylcholine pJ.aye:l 
in transmission at the skeletal neur.l':)muscular junction by demonstrating 
a substance identifiable as acetylcholine in the perfusion fluid after 
indirect stimulation of the hind limb muscles of the cat. Injection of this 
substance into arteries supplying the gastrocnemius muscle caused a quick 
~·--_...,;,...-------------------------, ~ 
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contraction of the muscle (Brown, Dale and Feldberg, 1936), though none 
was demonstrated during activity of denervated muscle (Dal~, Feldberg 
and Vogt, 1936). fubsequent work has confirmed that stimulation of 
motor nerves in isolated muscle preparations causes the release of 
acetylcholine (S;raughan, 1960). 
It appears that skeletal muscle contains small amounts of acetylcholine 
and that, in the denervated muscle, some acetylcholine may be present in 
the S:hwann cell remnants of the nerve (Birks, Katz, and Miledi, 1960}; 
thus, both resting and denervated musclcu release some acetylcholine 
(S;raughan, 1960; Krnjevic' and Mitchell, 1961; Mitchell and S.lver, 1963). 
Krnjevic' and S:raughan (1964} showed that the mean release of acetylcholine 
in resting denervated rat diaphragm was 1/2 of that in normal muscle. 
However, innervated stimulated muscle liberates some six times m·ore 
acetylcholine than either resting innervated or active denervated muscle 
(KrnjP.vic' and S;raughan, 1964). "Results of Hayes and Riker (1963) that 
there was no difference of acetylcholine release upon stimulation of.· normal 
and denervated rat diaphragm seem anomalous and the basic contention of 
Dale and Feldberg (1934) and Dale, Feldberg and Vogt, (1936}, remains. in 
full force today " (Karczmar, 1967}. 
Tt should be mentwned that Nachm<-<-nsohn, on the basis of biochemical 
studies, does not accept this classical theory of neurohumoral transmission 
20 
and claims that acetylcholine does not act between cells, but that it is the 
essential trigger for the initiation of permeability changes which permit 
/ 
ion movements across excitable membranes in general. Its role is 
basically s~milar for all membranes whether they are conducting or 
snyaptic membranes. 
a. Synthesis of acetylcholine 
Cholinergic fibers contain an enzyme, choline acetylase, which in tne 
presence of adenosinetriphosphate forms acetylcholine by transferring 
acetate from acetyl coenzyme A to choline (Nachmansohn and Machado, 
1943). Acetylcholine, choline acetylase, and cholinesterase (responsible. 
for the destruction of the transmitter) are not confined to the nerve 
terminals but are found in significant amounts along the whole length of the 
nerve trunk. A few days after severing a nerve axon, acetylcholine, 
choline acetylase, and cholinesterase accumulate at the proximal stump 
and disappear from the peripheral portion of the nerve (Hebb and Waites, 
1956; Sawyer, 1946). It has been suggested, therefore, that the 
enzymes are synthesized in the nerve cell body and are carried to the 
nerve endings by the axoplasmic current streaming down each fiber 
(Macintosh, 1959; Koelle and Koelle, 1959). 
Maclr-tosh has concluded that glucose (or lactate or pyruvate, which 
could replace it) is essential for acetylcholine synthesis. This is because 
the formation of acetyl-GoA, and therefore of acetylcholine, might be 
.,....-
------------------------------------------------------~ 
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inadequate to maintain the transmitter stores at their nor!l)B.1level in 
the absence of an extracellular source of acetyl groups. It is also clear 
that the level of extracellular choline is an important limiting factor 
for acetylcholine turnover during sustained activity at synapses (Birks 
and Macintosh, 1961}. Usually there is mo.,.e than enough choline in 
the plasma to support synthesis, no matter how heavy the traffic of 
nerve impulses. Choline, being a quaternary compound, is unable 
to penetrate nerve axons by passive diffusion; therefore, the nerve endings 
must extract the choline from the extracellular fluid. Birks and 
Macintosh ( 1961} have postulated a choline carrier in the terminal 
axonal membrane. The rate of acetylcholine synthesis in activated· 
nerve endings appears to depend also on the extracellular sodium concen-
tration; and there is good reason to believe that the speeding up of 
acetylcholine synthesis which accompanies activity is a consequence 
of the net influx of sodium into the nerve endings that also accompanies 
activity. During heavy activity the rate of acetylcholine synthesis at 
first lags behind the rate of acetylcholine release, catching up when 
the intra terminal sodium has risen far enough. 
How the intra·cellular sodium level controls acetylcholine synthesis 
is as yet a matter for speculation.· Since there is no reason to suppose 
~-------------------------------------~------------------------~ 
that sodium activates choline acetylase, one can presume that it is involved 
/ 
in some process governing the availability of the enzyme's substrates, 
choline and acetyl-CoA, at the sites of synthesis. 
b. S:orage 
The rate of acetylcholine discharge during nerve stimulation is 
matched by the rate of synthesis. When an anticholinesterase is present, 
the rate of synthesis is somewhat greater than the rate of discharge 
(Birks and Macintosh, 1961)_. There is also some synthesis when the 
nerve is at rest which has been shown to be as :much as ZO% of the 
maximum rate that is attained during activity (Birks and Macintosh, 1961). 
Thus, it can be said that the arrival of impulses at the nerve ending, 
besides triggering the release of acetylcholine, also stimulates its 
synthesis. 
The additional acetylcholine, which accumulates in a resting or an 
active ganglion whose cholinesterase has been inactivated, is clearly 
bound in a different way from the regular acetylcholine of the ganglion. 
Birks and Macintosh have called this "surplus" acetylcholine. This 
surplus acetylcholine accumulates within some intracellular compartment, 
in which, under ordinary circumstances, it would be destroyed by 
cholinesterase. Its formation shows that there is a continued synthesis 
z] 
and breakdown of acetylcholine in or near the nerve endings, even at rest. 
/ 
In terms of the vesicle hypothesis, one could say that surplus acetylcholine 
represents acetylcholine within the nerve endings but outside the vesicles. 
Using HC -3 as an inhibitor of acetylcholine synthesis Birks and 
Macintosh ( 1961) observed the maximum depletion of acetylcholine 
resulting from prolonged stimulation amounted to about 85o/o of the 
original store. The remaining 15o/o, which could not be released by 
nerve impulses, was designated as "stationary acetylcholine, 11 in contrast 
to the "depot acetylcholine" which could be released. Part of the 
stationary acetylcholine was located in the intraganglionic stretches of the 
cholinergic axons, since the acetylcholine of the preganglionic trunk was 
not depleted by activity in the presence of HC-3. The depot acetylcholine 
appears to be made up of a smaller "readily releasable" fraction, and a 
larger fraction which serves as a reservoir from which the first is 
replenished. Exactly how this is accomplished is not known but the idea 
of mobilization, i.e., the transfer of synthesized transmitter quanta into 
a form, or a site, in which they are more likely to be liberated by nerve 
impulses, provides a convenient basis for interpreting a number of 
phenomena associated with repetitive activity at cholinergic nerve endings. 
c. Release 
Even in the absence of nerve impulses there is a spontaneous release 
2'1 
of acetylcholine from the nerve endings giving rise to minute voltage 
fluctuations in the region of the motor end-plate (m. e. p. p. '(} (Fatt and 
Katz, 1952). On the arrival of a nerve impulse there is a simultaneous 
release of a large number of quanta of acetylcholine. This is caused by 
a depolarization of the terminal causing an influx of calcium which alters 
the properties of the vesicles or the axoplasm just inside the membrane 
so that the vesicles spill their contents into the synaptic gap (Birks and 
Mac Intosh, 1957). Depletion of calcium reduces the output of acetylcholine 
and the frequency of miniature discharge. Magnesium ions have the 
opposite effect; an increase in magnesium ion concentration decreases 
acetylcholine output (Del Castillo and Engbaek, 1954; Hubbard, 1961). 
These findings suggest that acetylcholine release is determined by 
intraterminal ionized calcium and that the latter is derived from influx, 
accelerated by depolarization and dependent on extracellular calcium, as 
well as from the variable membrane store of bound calcium controlled by 
membrane potential. There has been postulated a calcium-independent 
fraction based on the observation that m. e. p. p. 's continue indefinitely 
in the absence of calcium in the bathing solution, and even in the presence 
of a chelating agent and high magnesium (Hubbard, 1961). However, in 
contradiction to this, Elmqvist and Feldman {1965a) have shown the 
disappearance of m. e. p. p. 's six hours after treatment with EDTA of the 
rat nerve diaphragm preparation. When calcium was applied electro-
/ 
phoretically to this preparation, focal post-synaptic potentials appeared 
demonstrating release of acetylcholine. Lack of calcium had no effect 
upon propagation of the nerve impulse. Changes in the action potential 
of the nerve terminal may not always be related to changes in acetylcholine 
release (Katz and Miledi, 1965c), indicating that calcium and nerve 
terminals depolarization may constitute two independent controls of 
acetylcholine release from the nerve terminals. 
Q 
Birks (1963) and Gage and Qu,6stel ( 1965) have suggested that sodium 
may also be involved in acetylcholine release. Blockade of the sodium 
pump appears to facilitate transmission. Birks (1963) suggested that an 
increase in intraterminal sodium is responsible for this effect. Elmqvist 
and Feldman (1965b) alternately have explained the effect as being due to 
a mobilization of calcium. Nishi, S:>eda and Koketsu ( 1965) have revealed 
that bivalent ions, including calcium, exert dual actions on membranes. 
Besides binding the membrane and controlling and limiting its permeability, 
they also act as charge carriers by penetrating the membrane. This 
second effect which is sodium-like may be involved in acetylcholine 
release. Takeuchi and Takeuc!li (1962} observed in their experiments with 
low sodium and normal calcium levels a depression of transmitter release 
caused by a reduction of nerve terminal action potential amplitude. 
26 
The work of Katz and his colleagues (Del Castillo and Katz, 1956) 
showed that the acetylcholine released at the motor nerve -ending by the 
/ 
nerve impulse produces an increase in the permeability of the post-
junctional element to various ions, thus causing it to be depolarized; the 
depolarization then triggers the spike in the post-junctional element and 
junctional transmission is completed. Microelectrode techniques have 
shown the quantity of acetylcholine necessary to produce a response is-
1. 5 X l0- 15 g.m. (Krnjevic'and Miledi, 1958), which, because of the 
narrow gap at the junction, is a concentration of approximately 1 X 10- 3M~ 
The combination of acetylcholine with its receptors on the end-plate paten-:-
tial reaches a threshold level {about 1/4 the resting value in the cat (Boyd 
and Martin, 1956) ) the membrane is short circuited and surrounding 
areas of the muscle membrane, still in the resting state, discharge into 
this current sink and a muscle action potential is initiated and propagates 
away from the end -plate region (Eccles, Katz, Kuffler, 1941 b). The 
amount of acetylcholine released is in excess of what is needed to reach 
threshold (Brown, 1937), and yet it disappears quickly allowing the 
end-plate to repolarize before the end of the refractory period of the 
muscle fiber. 
It is widely accepted today that the amount of depolarization of the 
nerve terminal determines how much acetylcholine is released. E. p. p. 's 
are produced by acetylcholine released from presynaptic terminals 9-nd the 
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fr.::quency of m. e. p. p.ts. {but not their quantal size) are greatly increased 
by the application of depolarizing currents to the presynaptic {erminals 
and are decreased by hyperpolarizing currents (Del Castillo and Katz, 
1954; Liley, 1956). Hyperpolarization of the terminal is known to increase 
the amplitude of the presynaptic spike. This also leads to an increased 
end-plate potential which is generally used as an indicator of the amount of 
acetylcholine released. Presynaptic amplitude and e. p. p. does not always 
obtain an exact relationship _especially after conditioning of neuromyal 
transmission (Hubbard and S:::hmidt, 1963). Del Castillo and Katz ( 1954) 
have referred to a ''dielectric breakdown" of the membrane in the hyper-
polarized state and noted random bursts of m. e. p. p.' s. in this situation. 
Katz and Miledi (1965a) ru~gest that hyperpolarization of the terminal may 
be regulated by inside-outside sodium concentration, and block of the 
sodium pump by drugs may cause accumulation of sodium in the cell and 
lowering of the potential with consequent prevention of postetanic 
facilitation. 
Katz ( 1962) summarizes all the results by saying that "the frequency 
of the miniature potentials is controlled entirely by the conditions of the 
. 
presynaptic membrane, while their amplitude is controlled by the 
properties of the post synaptic membrane." 
28 
D. Cholinesterase 
Cholinesterase is responsible in part for the rapid disap~arance of 
acetylcholine but the end-plate potential is still short-lasting in the presence 
of cholinesterase inhibitors (Eccles, Katz, and Kuffler, 1942). Other 
mechanisms for th~ rapid removal of acetylcholine such as rapid diffusion 
to subthreshold concentration (Ogston, 1955) or resynthesis to a chemical 
precursor (Abson and Bjarke, 1945) have been suggested. The presence of 
cholinesterase may be merely an emergency mechanism for the removal of 
abnormally excessive amounts of acetylcholine. However, the artificial 
conditions of some animal experiments may be what cause it to appear 
unnecessary (Blaber, 1962). 
The existence of an enzyme responsible for the destruction of the 
humoral transmitter was suspected by_Loewi (1921) early in his studies of 
the "vagusstoff" and later demonstrated by Loewi and Navratil {1926). 
Later studies showed that those portions of skeletal muscle which had a high 
concentration of motor end-plates also contained the most acetylcholinester-
ase (Couteaux and Nachmansohn, 1940). The classic investigation by 
Marnay and Nachmansohn (1937) demonstrated that there was enough 
acetylcholinesterase in the end-plate region of the frog to hydrolyse the 
amount of acetylcholine calculated to be released from the nerve terminal 
during the few milliseconds of the refractory period. 
Koelle and Friedenwald (1949) first showed histochemically the 
e:x:istence of a high cholinesterase activity at the level of the thotor end-
plate. Barrnett (1962), using rat diaphragr:n, has added new knowledge 
concerning the localization of cholinesterase at the myoneural junction. 
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The structures that demonstrated enzyme activity were the muscle plasma 
membrane covering the junctional folds, the material in the primary and 
secondary clefts, the plasma membrane covering the axon terminal and 
vesicles and granules within the terminal axon. These findings put the 
enzyme activity on both sides of the junction. The entire plasma membrane 
of the axon did not show activity; only irregular short lengths of the membran:: 
were coated with the final product. These were interrupted by short seg- . 
ments of unstained membrane or gaps in which no surface membrane could 
be made out. 
The synaptic vesicles showed variations in activity. In some cases 
this was expressed by staining of the membrane which surrounded the 
vesicle, while in others only a part of the membrane was stained and in 
still others the entire content of the vesicle showed activity. Occasional 
linear segments of membranous material or short profiles of tubules were 
reactive. In some specimens, however, much of the final product appeared 
in morphological forms unrelated to any of the known structures found in 
the terminal axoplasm. These consisted of granules, rods, and arc seg-
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ments and were localized in the most peripheral parts of the axoplasm of the 
nerve terminals. It should be recognized that vesicular and gi'anular 
patterns of deposition may be the result of many factors, including sec-
tioning, incubation or subsequent preparation. 
These results do not support the speculation of De Robertis and 
Bennett (1955) that the vesicles are associated with transmitter substance, 
for any mediator would be destroyed by the cholinesterase. Barrnett's 
conclusion is thathis results supportNachmansohn's {1959) view ofnerve 
muscle transmission that acetylcholine acts in both the pre- and post-
synaptic membranes to permit ion flux, as occurs in axonal conduction. 
.,.... 
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III. PHARMACOLOGY 
Numerous compounds capable of facilitating neuromuscul(r trans-
mission have been synthesized. Many of these have been shown to possess 
anticholinesterase activity, and it was natural to ascribe the effects of 
these compounds on skeletal muscle to inhibition of the enzyme at the 
neuromuscular junction with the c0nsequent preservation of the transm1tter. 
In recent years the lack of correlation between the ability of certain of 
these compounds to facilitate neuromuscular transmission and to inhibit 
cholinesterase in vitro has led to research which has shown that some of 
these compounds cause at lease a part of their facilitating action via other 
mechanisms {Randall, 1950; Wescoe and Riker, 1951; Riker, 1953; 
Karczmar, 1957; Blaber, 1960; Riker, 1960; Blaber and Bowman, 1962; 
Edwards and Ikeda, 1962; Blaber, 1963; Standaert, 1963; Goode, Blaber, 
and Karczmar, 1965; Kato and Fujimori, 1965; Hubbard, Schmidt, and 
Yokota, 1965). {Figures Z(A) and Z(B). 
A review of the classical mode of action of the compounds involved in 
the present study will precede a review of more recent research which 
points to newer sites of action for these compounds at the neuromyal 
junction. 
A. Neostigmine 
Neostigmine is a synthetic anticholinesterase which was developed as 
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an outcome of the studies of the cholinesterase inhibiting properties of 
physostigmine. Although there is little difference between~ in~ 
potencies of neostigmine and physostigmine to inhibit cholinesterase in 
various species (Nachmansohn, Rotherberg and Feld, 1948), the anti-
curare and twitch potentiating action of the former drug is much more 
rapidin onset than that of the latter (Riker and Wescoe, 1946). The 
rapidity of action of neostigmine compared to that of physostigmine can 
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·probably be ascribed simply to a more rapid rate of combination with the 
receptors (Blaber, 1962). 
In the rat diaphragm, neostigmine antagonizes not only the 
neuromuscular paralysis by curare but also paralysis by depolarizing 
blockers such as decamethonium (&cher, 1951). This antagonism of 
depolarizing blockade does not hold tr~e in the cat because an increase 
of the blockade is observed (~owman, 1962). Neostigmine is known 
to have a direct action at the neuromuscular junction in addition to its 
anticholinesterase action (Riker and Wescoe, 1946) but this has been 
shown to be too weak to contribute to its action at the neuromuscular 
junction (&nith, Cohen, Pelikan and Unna, 1952; Hobbiger, 1952; Blaber, 
1962). Berman-Reisberg (1957) showed that neostigmine inhibited 
choline-acetylase, but 8 X 10-3 M was necessary to cause 50o/o inhibition 
which is strikingly different from the potency to inhibit acetylcholines-
terase, 50o/o inhibition being produced by 2. 8 X ~o-7 M, i.e., at a 
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concentration of approximately 40,000 times less. The finding that drugs 
of this type potentiate the action of applied acetylcholine is ~rely a 
demonstration that, in sufficient concentration, they possess an anti-
cholinesterase action. The question of whether this is the sole, or even the 
main mechanism of action of these compounds in the effective doses is not 
answered. 
B. Edrophonium 
The compound edrophonium is a particularly interesting substance 
because it reveals some of the weaknesses in the experimental methods. It 
is a quaternary compound which inhibits cholinesterase reversibly by 
combining with it only at the anionic site, and thus blocks attachment of the 
substrate (Holmstedt, 1959). The rapid onset and short duration of action 
of edrophonium with respect to neostigmine has been noted by a number of 
investigators (Cowen, 1938; MacFarlane, Pelikan and Unna, 1950; Riker, 
19'53; Wilson, 1955). The ability of this compound to reverse the neuro-
muscular blocking action of tubocurarine is well known also, but the 
earliest experiments indicated that it was only a feeble anticholinesterase, 
about one-hundredth as potent as neostigmine (Randall, 1950; Hobbiger, 
1952). fullth, Cohen, Pelikan and Unna (1952) obtain~d results which 
showed no .positive correlation between the relative potencies of the 
compound as an anticholinesterase and its ability as potentiator of 
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acetylcholine on the frog rectus muscle. The inhibition of cholinesterase 
by edrophonium was reversed by the addition of substrate too/rapidly for the 
time course to be measured with the manometric technique. The ev1dence 
outained neither directly confirmed uor negated the thesis that the 
potentiation of acetylcholine and antagonism of tubocurarine produced by 
this compound is the result of its ip.hibition of cholinesterase {Snith, Mead 
and Unna, 1957). 
Direc" depolarization of the end-plate memorane with edrophonium 
can be achieved by application of concentrations that are 100 times that 
shown to be effective in antagonizing curare {Nastuk and Alexander, 1954). 
C. Oxamides 
Ambenonium Cu..1.0r1de (Mytelase; W !N 8077) and metnoxyambenonium 
Cu.LOride (WI.l\1 8078) are members of a series of bisquaternary oxamides 
synthesized in the Sterling-Winthrop laboratories and first reported by 
Arnold, &>ria and Kirchner ( 1954). Both are synergistic with neostigmine 
i'!l mice and have been shown to be reversible inhibitors of acet:j:c!tolines-
terase {Karczmar and Howard, 1955; Koelle, 1957; Blaber; 1960; .. Goode, 
Blaber and Karczmar, 1965). In this regard it was found that ambenonium 
is more than 100 times a3 active as methoxyambenonium. Ambenonium 
reversal occurs extremely slowly except in the presence of relatively high 
concentrations of certain cations (Koelle, 1957). Ambenonium potentiates 
the respo.nse to the indirect single shock stimulation of cat muscle and 
/ 
antagonizes curare blockade. Although a powerful anti-curare agent, 
methoxyambenonium does not potentiate the maximal twitch tension 
(Lands and Karczmar, 1955; Blaber, 1960). In the frog, ambenonium 
augmented and prolonged the end-plate potential and acetylcholine 
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depolarization (Karczmar, Kim and Koketsu, 1961); methoxyambenonium 
. only augmented but did not prolong these phenomena. While ambenonium 
augments the excitatory and_ paralyzing action of acetylcholine, succinyl-
choline and decamethonium on the cat1 s tibialis muscle, methoxyambenonium 
diminishes these effects (Karczmar, 1957). Since methoxyambenonium an-
tagonizes paralysis by curare and depolarizing agents as well, Karczmar 
stressed that the current theories on the mode of action of the depolarizers 
offe:red an inadequate explanation for the properties of methoxyambenonium. 
Blaber (1960), finding that both compounds antagonized the paralysis of 
curare and depolarizers, ar:dved at the conclusion that larger doses than 
those required to antagonize curare are needed to restore transmission 
from paralysis by decamethonium. Blaber also found that at these higher 
doses, oxamides produced a neuromuscular block resembling, in many 
ways, that caused by curare. Accordingly, he suggested that the 
antagonism of depolarizers was due to the curaremimetic properties of the 
oxamides. 
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The complexity of the detailed mechanism of action of the oxamides is 
/ 
apparent. There is no correlation between the relative potency of these 
agents to antagonize curare paralysis and their cholinesterase inhibitor 
potency in vit::.£· While the neuromuscular block by oxamides resembles 
that by curare since it is antagonized by tetanic stimulation and depolarizing 
agents, it is unlike that produced by curare in that it is not antagonized by 
neostigmine or edrophonium (Blaber, 1960). 
D. Depolarizers_ 
In the search for synthetic agents capable of blocking neuromuscular 
and autonomic ganglionic transmission, that is, for substances blocking 
the nicotinic effects of acetylcholine, thousands of interesting compounds 
have been made and scores of chemical series·explored. One of the most 
fruitful discoveries was that of the British investigators who introduced 
the polymethylene bis-trimethyl-ammonium series, referred to by the 
generic term 11 methonium compounds. 11 This class of drugs was developed 
simultaneously and independently by Barlow and Ing ( 1948) and Paton and 
Zaimis (1949). Potency was greatest in the bis-trimethylammonium series, 
and unusually high activity at the neuromuscular junction was found when 
the chain contained ten carbon atoms (decamethonium; C 10). The action 
of these compounds is not like that of tubocurarine. They act like 
acetylcholine in producing contracture of the frog rectus (Paton and 
Zaimis, 19•1:9) or the chick biventer (Gins borg and Warriner, 1960), they 
depolanze the end-plate or the eat's gracilis muscle (Burns and Paton, 
/ 
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1951} and desensitize the end-plate of the tenuissimus muscle of the cat to 
acetylcholine applied electrophoretically (Axels son and Thesleff, 1958}. 
The ability to cause contracture of the frog rectus depends upon chain 
length and is not actually maximal in decamethonium (Klupp, K:ra upp, 
Stormann, and Stumpf, 1953}. If given close arterially into the anterior 
tibialis muscle of the cat they produce two types of responses. After a 
latent period, a small dose _produces fasciculations, while a larger dose 
causes an immediate muscle twitch followed by fasciculations (Paton and 
Zaimis, 1949, 1951). Decamethonium has been shown to inhibit cholines-
terases, 50o/o inhibition of human plasma and rabbit erythrocyte 
cholinesterase being produced by 6. 0 X 10-5 M and 4. 5 X 1Q-5 M 
concentrations respectively (Paton and Zaimis, 1949). 
Succinylcholine (Bovet, Bovet-Nitti, Gua ... ino, Longo and Marotta, 
1949}, another depolarizer, has been found to be a substrate for butyro-
cholinesterase (Glick, 1941) and it also inhibited human red cell 
acetylcholinesterase; 2. 5 X 10-3M produces 50o/o inhibition (Evans, et. al., 
1952). (Figure 3). 
The block of neuromyal transmission due to these agents can be 
antagonized by tubocurarine. However, depolarizing agents synergize with 
ant cholinesterases (Zaimis, 1951, 1959). Anticholinesterases increase 
,..... ... 
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the initial potentiation of muscle twitch by succinylcholine or decamethonium 
/ 
and then intensify and prolong their blockade. One explanation of this 
phenomenon could be the protection of acetylcholine released upon nerve 
stimulation which then could synergize with and prolong decamethonium 
depolarization. It has also been pointed out by Nastuk and Alving { 1959) 
that anticholinesterases containing onium grouping such as neostigmine 
and edrophonium are depolarizing agents in their own right and thus could 
synergize with decamethonium and succinylcholine. Karczmar has 
shown that certain oxamide compounds not only antagonize curare and 
depolarizing types of blockade but convert the depressant action of 
depolarizers upon the twitch response into .a pure excitatory effect, which 
he refers to ,as "reversal11 {Karczmar,_ 1957; Karczmar, Kim, and Blaber, 
1965; Blaber and Karczmar, 1967). Oxamides, as well as hydroxyanili-
niums, increase the e. p. p. obtained when neu:romyal transmission is 
blocked not only by d-tubocurarine, but also by succinylcholine and 
decamethonium {Karczmar, Kim, and Koke~su, 1961; Karczmar, et. al., 
1965). This may be related to the fact that blockade by depolarizers may 
have a competitive, d-tubocurarine-like component of action {Zaimis, 1951, 
1959; Thesleff, 1955). This component is particularly pronounced in the 
frog. 
Experiments using C 14 decamethonium show that fixation and distribu-
tion of decamethonium in the end-plate are different from those 
of curarine (Waser, 1965). Not only the end-plate itself is occupied but 
/ 
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also a wide area around this, varying. with the time interval. According to 
earlier hypothesis, the site of action of cholinergic molecules such as 
acetylcholine, muscarine, and decamethonium are the cholinergic 
receptors in the postsynaptic membrane of the end-plate in the vicinity of 
pores (Waser, 1961). These pores are essential for ion transport during 
depolarization. Their 0bstruction leads to a curare -like neuromuscular 
block, whereas persistent opening leads to paralysis by depolarization. 
The well-known change between depolarizing paralysis and hyperpolarizing 
block observed some time after injection of decamethonium might thus be 
due to an accumulation of molecules around the pores,. followed by 
obstruction of these to permeation of the postsynaptic membrane {Jenden, 
Kamijo and Taylor, 1954}. 
E. D-tubocurarine 
Eince early demonstration of the decurarizing effect of eserine by 
Pal ( 1900) and Rothberger { 190 1), the antagonism by neostigmine, 
oxamides, edrophonium-like compounds and other reversible anticholin-
esterases of the depression by d-tubocurarine of neuromyal transmission 
has been amply demonstrated in the frog (Rosenblueth, Lindsley and 
Morison, 1936) and mammals (Snith, Cohen, Pelikan, and Unna, 1952). 
This antagonism extends to both single twitch and tetanus response to 
~ 
---------------------------------------------------------------, 
indirect stimulation, as shown by Briscoe ( 1936). Its blocking action on 
/ 
transmission is particularly pronounced during the tetanus; it is 
cumulative and frequency dependent, although this latter effect is not as 
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pronounced as in the case of drugs inhibiting the synthesis of acetylcholine. 
This is a reciprocal action, d-tubocurarine being capable of antagonizing 
neuromyal depression by anticholinesterases (Briscoe, 1936). It is an 
important point; because it illustrates a basic difference between 
neuromyal block by anticholinesterases and d-t:ubocurarine. 
D -tubocurarine i~ a non-depolarizing blocking agent of neuromuscular 
transmission, competitively antagonizing acetylcholine at the neuromyal 
junction.lwhich first converts the spike into .the e. p. p. and then reduces the 
latter (Thesleff and Quastel, 1965). As a competitive blocker, d-tubocurar-
-
ine is antagonized by agents which release acetylcholine such as TEA 
(Koketsu,. 1958; 3:ovner, 1958), by depolarizers, and by anticholinesterases. 
D-tubocurarine has been shown to oppose the increase in duration and 
amplitude of the e. p. p. produced by anticholinesterases (Eccles, Katz 
and Kuffler, 1942; Feng and Li, 1941) and hydroxyaniliniums (Karczmar, 
Kim and Koketsu, 1961). 
Takeuchi and Takeuchi (1960) measured the effect of d-tubocurarine 
on the end-·plate current, which is directly proportional to the extent of 
occupation, by acetylcholine of the cholinergic re<:eptor sites (Eccles, 
X \ 
1964). It was found that antagonism of d-tubocurarine of neuromuscular 
/ 
transmission extends to the end-plate current. 
Eccles, Katz and Kuffler ( 194lp) showed that there is a diminution 
of the e. p. p. by d-tubocurarine which is due to the prevention by it of 
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acetylcholine depolarization of the end-plate. This action allows a larger 
fraction of the acetylcholine to be free and therefore available for 
enzymic destruction. 
Waser (1959), using radioactive tubocurarine and decamethonium, 
identified receptorswh~ch bound these substances in the end-plate region. 
Denervation produced spreading of the sites which bound the depolarizers 
but caused disappearance of those binding Gurare. 
F. Nerve Terminal As a S.te of Action 
Recent research with the compounds involved in the present study has 
shown that the nerve terminal is a site of action for them. Although much 
-
of the work has been carried out in the last ten yeare, drug induced responses 
on the terminal were observed almost 30 years ago. 
In 1940, Masland and Wigbn showed in cats that repetitive firing 
in muscle fibers produced by neostigmine was accompanied by repetitive 
antidromic activity in the nerve. They interpreted their results to mean 
that the action of neostigmine was not a direct one, but when cholinesterase 
was inhibited, the released transmitter was allowed to act on the nerve 
endings. Feng and Li (1941) observed the same response using physostig-
-mine but concluded that the antidromic activity in the nerve was a 
consequence of a direct action of the compound upon the motof terminal. 
Lloyd demonstrated in the following year ( 1942) that action currents 
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in the muscle could re-excite the nerve and lead to antidromic responses. 
Therefore, he suggested that the nerve excitation demonstrated in the 
presence of physostigmine was due to the induced repetitive firing of the 
muscle. Eccles, Katz and Kuffler ( 1942) reached the same conclusion as 
Lloyd although they were of the opinion that a fraction of the repetitive 
nerve activity preceded that in the muscle and could not, therefore, have 
been induced by the muscle action currents. 
Riker and coworkers (Riker, Roberts, S:andaert and Fujimori, 1957;, 
Riker, Werner, Roberts and Kuperman, 1959 a & b) studied theeffects of 
several phenyltrialkylammonium salts which also caused repetitive firing 
on the nerve. In experiments in which the root filaments and the muscle 
units were carefully matched, it could often be seen that the repetitive 
nerve spike actually preceded that of the repetitive muscle spikes. fuch 
results seemed to exclude the possibility of retrograde activation of the 
nerve by the muscle action currents as suggested by Lloyd, 1942). Riker, 
et. al. ( 1957) also pointed to the lack of correlation be_tween anticholin-
esterase ac;tivity and ability to induce repetitive firing in the nerve among 
their series of comp0unds, and in contrast to Masland and Wigton they 
concludedthat the drugs acted directly on the nerve endings. Brown and 
~ 
--------------------------------------------------------------, 
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Matthews (1960) confirmed the results of Lloyd (1942) and established the 
/ 
fact that currents generated in active muscle could ephaptically re -excite 
motor nerve endings and that the time course is such that the re -excited 
nerve endings can again excite the muscle. The work of Lloyd ( 1942) and 
Brown and Matthews (1960) showed that almost the whole of the summed 
muscle action currents were necessary to back-excite the nerve endings, and 
that the back-response was abolished by using a submaximal orthodromic 
nerve volley. 
Blaber (1962), comparing the same facilitatory drugs as used in the 
present work, found that their ability to potentiate the muscle contraction 
produced by a close -arterial injection of ac.etylcholine was closely corre-
lated with their_!_~ vitro anticholinesterase potency. However, there was no 
correlation between in vitro anticholinesterase potency and their ability 
to potentiate the muscle twitch elicited by the stimulation of the nerve or 
. with their anti-curare activity. Blaber then tested the action of these 
compounds (neostigmine, edrophonium, methoxyambenonium, ambenonium) 
for an action on the nerve terminal and showed that the duration of 
repetitive discharges produced by close-arterially injected edrophonium 
and neostigmine was approximately 50 milliseconds following each main 
nerve spike. This corresponded closely with the 'Cluration of the negative 
after potential of the nerve terminal as recorded by Hubbard and S:hmidt 
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{ 1961}. Ambenonium was observed to cause antidromic firing for 300 
milliseconds and methoxyambenonium was the only drug stu_9ied which,. by 
itself, was unable to elicit antidromic activity in motor axons (Blaber and 
Bowman, 1963B}. Blaber concluded by suggesting that these compounds 
potentiated the after potentials of the terminal, thereby giving rise to an 
increased release of acetylcholine which prolonged the end-plate potential. 
Depolarization of the end-plate and sensitization of the end-plate did not 
contribute to the facilitating action of the compounds studied in Blaber' s 
experiments. The inhibition of cholinesterase seemed to be important 
only in the case of ambenonium (Blaber, 1962}. 
Werner ( 1961} using a divided nerve where the muscle action current 
was too small to produce a back response in the nerve, demonstrated 
repetitive activity in ventral root fibers following facilitatory agents. These 
data showed that the antidromic firing in the motor nerve was not a 
consequence of the repetitive muscle action-currents. Werner ( 1961} also 
concluded that the time from the stimulus to the appearance of the 
ephaptically induced back-response was considerably shorter than would 
be expected if the site of initiation of the back-response was the motor 
nerve terminal. He therefore concluded that the ephaptically induced 
back-response, was not initiated at the nerve terminals but at some 
myelinated part of the intramuscular axons. With the use of paired stimuli 
in the presence of facilitatory drugs, Werner (1960 a) obtained data which 
5 uggested that the facilitatory agents augment the after potentials in the 
nerve terminals and that the augmented negative after potential acts as a 
current sink for neighboring parts of the axon, thereby generating 
repetitive firing in the nerve. Hubbard and S:hmidt (1961) substantiated 
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Werner's data using mic roelectrodes to stimulai::e the :1.erve te::.-minals. 
Neostigmi-:-te in concentrations d 10 -? g/ml caused a reversible increase 
in the refractory period of the nerve terminals and in the negative after 
potentials. The authors point out that the increased refractory period 
probably indicates a prolongation of the spike potentials in the terminals, 
suggesting that part of the effect of neostigmine on the end-plate potential 
is caused by a prolongation of the period of transmitter release. 
Recently, depolarizing compounds have been shown to have an action 
on the motor nerve terminal (Adams, Deitrich and Gordon, 1963; 
Edwards and Ikeda, 1962; Standaert, 1963; Standaert and Adams, 1965). 
This phenomenon is similar to that following the administration of 
anticholinesterase and related agents. The non-ephaptic character of the 
antidromic discharge is not as well substantiated as that of the anti-
cholinesterases and part of the antidromic response to large doses of them 
may be due to ephaptic conduction from the muscle to the terminal (Kato 
and Fujimori, 1965). 
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3:ill another compound which has been shown to have a terminal action 
/ 
is curare. Riker ( 1960) and S::andaert ( 1964) observed an antagonism by 
d-tubocurarine of the lowering of the nerve terminal threshold by 
acetylcholine. This and the disappearance of antidromic firing induced by 
hydroxyaniliniums after the administration of small doses of curare, caused 
them to suggest involvement of the nerve terminal in the mechanism of 
action of curare. 
The effects of acetylcholine on the nerve t.erminal are pertinent with 
regard to the nerve ter:r:ninal theory of drug action. Hubbard, S:hmidt and 
Yokota (1965) found no increase in the frequency of m. e. p. p. 's or in the 
quantal content of the e. p. p. 's in the rat ph;renic nerve diaphragm prepara-
tion in which quanta! component of the e. p. p. was reduced by high 
magnesium. After neostigmine, acetylcholine decreased the quanta! content 
of m. e. p. p. 's and still exerted no meaningful effect on the frequency of 
-
acetylcholine release. Yet, acetylcholine lowered the threshold of the 
nerve terminal response to a cathodal pulse. One set of experiments 
seems to show that acetylcholine does not depolarize the terminal, while the 
second set seems to imply that it does. Hubbard suggested that acetylcholine 
was depolarizing at the node or nodes of Ranvier. The depolarizing effect 
at this site was insufficient to increase acetylcholine release, but sufficient 
to lower the threshold. 
""' ... 
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The purpose of the present experiments will be to attempt to show 
/ 
how the compounds excite at the terminal location. Do they stimulate 
directly or is their effect mediated through acetylcholine? Do the 
depolarizers have a different mode of action at the terminal than the 
facilitatory compounds? What interaction exists between these compounds 
at the terminal? Is there more than one site for drug action at the 
terminal? These are some of the questions which we will attempt to answer 
in the present work. 
/ 
MATERIALS AND METHODS 
,.... 
I. IN VIVO EXPERIMENTS 
Experiments were performed on ?· 5 - 3. 5 kg. cats and tlfe elements 
of the method employed are schematized in figure 4. Atropine sulfate 
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1. 5 mg. /kg. I. P. was administered to all cats. Ane thesia was instituted 
by chloralose 60-80 mg. /kg. I. P. and 5 mg./kg. pentobarbital sodium. 
The pentobarbital was used to decrease the initial stage of excitement due 
to chloralose. The animals were then fastened to the operating table in a 
prone position and the trachea cannulated. A polyethylene cannula was 
placed iti the right carotid artery and connected to a Stratham pressure 
transducer for the purpose of recording blood pressure. To prevent 
clotting, this cannula was filled with heparin dissolved in 0. 9o/o NaCl 
(200 units per ml. ). Blood pressure was rec9rded to provide an index of 
the animal's condition during the experiment. 
A. Preparation for the administration of drugs 
The left jugular vein was cannulated for intravenous drug administra-
tion. The polyethylene cannula was connected to a three -way stopcock 
and clamped to a support on the operating table. In experiments requiring 
close arterial injection of the test drugs, Blaber's 1960 modification of 
Brown's 1938 method was used. The artery to the anterior tibialis muscle 
was cannulated and the cannula filled with heparin solution {100 units per 
ml.), plugged until ready for use and fastened to a support on the operating 
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table. For distal arterial injection of drugs the left femoral artery was 
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exposed on the posterior surface of the thigh and cannulated. The cannula 
was inserted until the end was approximately at the aortic illiac junction. 
This was to insure that injections into this cannula would proceed into the 
right leg. 
B. Recording of mechanical response 
The right anterior tibialis muscle was exposed from mid-calf level to 
its tendon insertion. The tendon was ligatured and cut from the bone of 
its i.nsertion. Pointed drills 3/16 inch in diameter and 3 inches in length 
were placed through the distal end of the femur, and the distal ends of the 
tibia and fibula. By means of the drills, the leg was mounted in a horizontal 
plane to the operating table. This provided rigid fixation and permitted the 
opening of the popliteal fossa. The fossa was then opened and the fat remov 
Thread was passed around the femoral artery to permit occlusion for close 
arterial injection via the tibial artery, thus assuring that the drug passed 
into the tibialis muscle. The tibial nerve was identified and isolated in the 
fossa and extraneous connective tissue removed prior to placement on 
platinum stimulating electrodes. The common peroneal and sural nerves 
were separated and cut distal to their junction with the sciatic to prevent 
movement artifacts. A shielded platinum electrode was placed on the 
tibial nerve distal to the junction with the sciatic nerve and connected to a 
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Bioelectric Instrument isolator which received pulses from a stir11ulator 
/ 
consisting of a Tektronix type 162 waveform generator and a Tektronix 
type 161 pulse generator. The pot-liteal fossa was then filled with warm 
mineral oil. The ligature around the tendon of the muscle was connected 
to a Grass model FT-10 force displacement transducer for the purpose of 
recording mechanical twitch. Rectangular pulses of 50~ sec. duration, and 
twice the strength required to evoke a maximal muscle action potential were 
applied once every 10 seconds through the shielded platinum electrodes 
placed on the tibial ner_ve in the popliteal space. Except where otherwise 
stated the stimulating electrodes were placed so that the cathode was 
nearest to the ventral root. A temperature probe was placed in the belly of 
the muscle and the muscle covered with a surgical sponge moistened with 
mineral oil saturated with 0. 9o/o sodium chloride. The muscle was 
maintained at 37° C with heat lamps. 
C. Recording of muscle potential 
Muscle potentials were recorded by means of a concentric needle 
electrode. The potentials were amplified by a Tektronix type 122 low-
level preamplifier and displayed on a Tektronix type 562 storage oscillo-
scope and photographed by means of a Tektronix 35 mm. camera or displayed 
on a Tektronix type 502A dual beam oscilloscope and recorded on 35 mm. 
film using an Analab oscilloscope camera using single frames or continuous 
motion magazines. 
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D. Preparation of spinal cord 
Laminectomy was performed to expose the lumbar cor/ A skin 
incision of the back was made from L-3 to S-3. Both sheets of the lumbar-
dorsal fascia were incised and the multifidus spinae muscle was removed 
from L-4 to S-2. The longissimi dorsi muscle was cauterized through on 
both right and left sides at the level of L -7, but was not removed. The 
removal of the muscles was to cut down on fasciculations arising from 
. 
-drying as the experim~nt progressed and also to give more exposure in the 
spinal area. The vertebrae were then removed from L-5 through S-1 
exposing the spinal cord and its coverings. The dura mater was incised, 
reflected and held by means of straight pins pushed into the longissimi 
dorsi muscles at the L-7 level. This maneuver raised the cord for easy 
location of the spinal roots. The L -7 root was is alated intra spinally and 
the dorsal and ventral components detached from the cord. The ventral root 
was subdivided until an afferent tibial filament was located by monitoring 
the nerve potential with an oscilloscope. The skin edges around the 
exposed spinal cord were elevated to form a pocket which was filled with 
warm liquid paraffin saturated with 0. 9o/o sodium chloride.. The spinal oil 
pool was kept warm by means of a heat lamp. 
E. Recording of nerve potential 
Nerve potentials were recorded by placing a selected portion of the 
ventral root on bipolar platinum electrodes 5 mm. apart. The potentials 
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were amplified by a Tektronix type 122 low -level preamplifier and displayed 
/ 
on a Tektronix type 562 storage oscilloscope and photographed by means 
of a Tektronix 35 mm. camera or displayed on a Tektronix type 502A dual 
beam oscilloscope and recorded on 35 mm. film using an Analab oscillo-
scope camera with single frames or continuous motion magazines. 
F. Experimental procedure 
The blood pressure, muscle twitch, and temperature were all 
monitored on an Offner type R dynograph. After amplification by a 
Tektronix type 122 pre-amplifier, the muscle and nerve action potentials 
were monitored simultaneously on a Tektronix type 562 double beam storage 
oscilloscope and photographed on 35 mm. film. There was a 30 minute 
. 
control period of muscle twitches prior to the 'injection of drugs. After this 
control period test compounds were given either intravenously, close-
arterially, or distal arterially. These were given either in the presence of 
indirect stimulation (1/10 sec. or in some experiments 100/sec. /150M sec. 
10 sec.) or without stimulation. 
All drugs injected were dissolved in 0. 9% sodium chloride. 0. 9% 
sodium chloride was also used to wash the cannula after i. v. injections. 
A solution containing 100 units heparin/ ml. was used to wash the close 
arterial cannulae after injection. 
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II. IN VITRO EXPERIMENTS {MICROELECTRODE) 
The. usual techniques were employed for intracellular recording with 
/ 
capillary glass microelectrodes (Fatt and Katz, 1951}. Electrodes of 
between 5 and 15 M ohms resistance were used and special attention was 
paid to keeping the input time-constant of the recording circuit as small as 
possible. 
The tenuissimus muscle of the cat was removed from the anaesthetized 
animal and mounted in a c.onstant temperature bath. The chamber for the 
muscle and bathing fluid was constructed of plexiglas. The temp-erature 
was maintained at 37° C with the use of a Haarke constant temperature 
circulation pump. The muscle was bathed in prewarmed oxygenated 
Krebs's solution (Boyd and Martin, 1956) to which was added 30 ml. /L 
of isotonic glucose solution (final composition: sodium chloride, 115 mM; 
KC 1, 4. 60 mM; KH2P04, 1. 15 mM; NaHC03 , 24. 1 mM; CaC 12, 2. 46 mM; 
MgS04, 1. 15 mM; glucose, 8. 85 mM}. Oxygenation was effected by 
bubbling a 95o/o-5o/o C02 mixture into the solution before it passed into 
the muscle bath. The bath had a volume of 3 ml. which was. changed 
continuously at a rate of 200 ml. /hr. by dripping in fresh fluid and 
allowing the excess to overflow on one side to maintain a constant level. 
Superficial nerves were located visually and the end-plate located by 
the position where them. e. p. p. 'shad the greatest amplitude and shortest 
time course. 
~ 
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The drugs used, succinylcholine and decamethonium were added to 
/ 
the control Krebs' solution to give the appropriate concentration. The 
level of drug was increased by increments of 10 fold from 10-1 2 M until 
the end-plate depolarized. Them. e. p. p. 's were amplified using a 
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Nikkon hi-input impedence D. C. amplifier and a Tektronix 122 low .,.level 
A. C. preamplifier. They were monitored and photographed on a Tektronix 
502 dual beam oscilloscope until depolarization occurred. Each concen-
tration was infused for 10 minutes before any recordings were made. 
~ 
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Drugs and SJlutions: 
/ 
Atropine fulfate- (Matheson Coleman & Bell) SJlutions were made up in 
0. 9o/o sodium chloride to contain 10 mg. lml. 
Pentobarbital SJdium (Abbott Laboratories) 50 mg. I ml. 
a-Chloralose (City Chemical Corporation of New York) SJlutions were 
freshly prepared in 0. 9o/o sodium chloride to contain 10 mg. I ml. 
Heparin SJdium (Aero Chemical) SJlutions were made up in 0. 9o/o sodium 
chloride to contain 100 and 1000 units lml. 
Neostigmine Bromide (City Chemical Corporation of New York) SJlutions 
w<tre made up to contain 1 mg. I ml. 
Edrophonium (Hoffmann LaRoche {Tensilon) ) SJlutions were made up to 
contain 1 mg. lml. 
Ambenonium {Sterling-Winthrop (VVIN 8077) ) Solutions were made up to 
contain 1 mg. I ml. 
Methoxyambenonium (Sterling-Winthrop (WIN 8078) ) Solutions were made up 
to contain 1 mg. I ml. 
Decamethonium Bromide (Burroughs Wellcome (Syncurine; C10)) Solutions 
were made to contain 1 mg. I ml. 
fuccinylcholine Chloride {Travenol) Solutions contain 20 mg. lml. 
Acetylcholine Chloride {Merck) Solutions were made to contain 1 mg. I ml. 
Choline Chloride {Abco Chemical) Solutions were made up to contain 10 
,_ ___ m_[: lml. 
-Tubocurarine Chloride {Abbott) 3 mg. /ml. 
Hemicholinium (HC -3) (Dr. J. P. Long, University of Iowa}' Solutions 
were made up to contain 10 mg. /ml. 
~~", c2:"1t\'iLC1\o~ ,,.J_: ( 11/f\Q_\) I,;LC:,J ... ;J~_,p) 
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RESULTS 
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I. EFFECTS OF S:NGLE DRUGS 
-- / 
The production of antidromic motor nerve discharges in the presence 
or absence of orthodromic stimulation following the administration of 
facilitatory and depolarizing drugs has been previously reported (Masland 
and Wigton, 1940; Feng and Li, 1941; Riker, et. al., 1959; Werner, 
1960 a & b; Blaber, 1962; Blaber' and Bowman, 1963 a & b; Standaert, 1963) 
and has been discussed in the introduction to this thesis. In this section 
the drugs neostigmine, edrophonium, ambenonium, methoxyambenonium, 
succinylcholine and decamethonium have been tested for their ability to 
produce this effect. 
A. The effect of facilitating and d~polarizing drugs following 
s timulation by a single volley 
In these experiments single nerve shocks were delivered at intervals 
of 10 sec. A typical record of muscle and ventral root action potentials in 
re-sponse to a single :nerve stimulus is illustrated in figure 5. The anti-
dromic nerve spike in response to the stimulus was followed, about 2 msec. 
later, by a brief burst of small spikes which terminated about 5 msec. 
after the stimulus artifact. This secondary back discharge has been shown 
not to be directly elidted by the stimulus in the more slowly conducting 
fibers, such as the gamma-efferents, since it was completely abolished 
by cutting the nerve between the stimulating electrodes and the muscle 
(Blaber, 1962). 
,..-· 
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FIGURE 5 
/ 
L 
_J;l ____ _ 
2. 6 kg. Cat - Muscle action potential (upper trace) recorded from the 
tibialis muscle with concentric needle electrodes, and nerve action 
potential (lower trace) recorded antidromically from the ventral root. 
Voltage calibration: muscle SmV, nerve 100 ,uV; time calibration: 10 msec. 
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The presence of the back discharge is, therefore, clearly dependent 
on activity in the muscle and corresponded to the ephaptic bae'k response 
described by lloyd (1942) and, more recently, by Brown and Matthews 
(1960). As shown by Brown and Matthews (1960) the back response in the 
nerve would occasionally re-excite some of the muscle fibers. Observation 
of the response depended upon the position of the needle electrode. The 
ephaptic back response as seen in the ventral root was most clearly seen 
·with monophasic recording since with diphasic recording it is partly 
obscured in the positive deflection of the main antidromic spike. When the 
single stimulus applied to the nerve is reduced in intensity so that a sub-
maximal muscle response is produced, the back response in the nerve 
becomes progressively smaller and eventually disappears at a time when the 
muscle action potential is still approximately one half of its maximal size. 
This confirms the observations of Brown and Matthews that the summed 
action currents of almost all of the muscle fibers are necessary to 
ephaptically excite the motor nerve fibers. 
Close -arterial administration of neostigmine (2 ,ug), edrophonium 
(5 ,ug), or ambenonium (2 ,ug) or intravenous administration of succinyl-
choline (35 ,ug) or decamethonium (35 }..lg} caused , following orthodromic 
stimulation, the appearance of high frequency antidromic discharges in 
the ventral root ace ompanied by repetitive firing of the muscle fibers. 
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These effects are illustrated in figures 6 and 7. The first nerve spike in 
/ 
the repetitive train appeared between 5-10 msec. after the main antidrcrnic 
spike. In the cases of ambenonium, edrophonium, and neostigmine the 
firing was asynchronous and at the height of the effect had a time course of 
approximately 50-100 msec. following the injection of edrophonium and 
neostigmine, and 200-300 msec. after an injection of ambenonium. The 
firing, following each nerve spike, was observed to be present for 5-10 
minutes after edrophonium, for 30 minutes after neostigmine, and for 45 
minutes following ambenonium. The firing following an injection of 
decamethonium or succinylcholine was more synchronous than that of the 
above compounds and had a time course of approximately 100 msec. 
following each main nerve spike. The ephaptic response with these two 
compounds was greatly enlarged, sometimes to more than 400o/o of its 
original height. There was usually a slight block of the muscle twitch with 
the doses used, and the ephaptic response at this time would diminish and 
eventually disappear in many cases. However, antidromic firing was 
still present following the nerve spike. As the muscle proceeded into 
block this activity changed from a synchronous firing to one which 
resembled that obtained after an injection of one of the facilitatory compoul'Xi'3 
This firing was present until the muscle was at maximal block and then 
disappeared slowly. These effects may be seen in figure 8. A slight 
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FIGURE 6 
3. 7 kg. Cat -Antidromic nerve potentials recorded in the ventral root 
following a single nerve stimulus. a) Control; b) following 45 ,ug 
succinylcholine i. v.; c) 2 minutes later. Voltage calibration:100 uV; 
time calibration: 10 msec. 
FIGURE 7 
' 
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a. b. c. . . 
4. 6 kg. Cat - Antidromic nerve potentials recorded in the ventral root following 
a single nerve stimulus. a) Control; b) 5 ,ug edrophonium; c) 20 minutes 
laterc.a:Voltage calibration: 100 ,uV; time calibration: 10 msec. 
.. 
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FIGURE 8 
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c. d. 
2.4 kg. Cat- Antidromic nerve potentials recorded in the ventral 
root following a single nerve stimulus. a) Control; b) 20 ,ug decamethonium 
i. v.; c) 1 minute later; d} 2 minutes later after b. Voltage calibra-
tion: 100 ,uV; time calibration: 10 msec. 
~------------------------------------------------·---6-9-, 
asynchronous activity can be observed during the synchronous or 
/ 
facilitating phase of the depolarizing compounds and in the initial phase 
of the neuromyal block. The asynchronous activity became more apparent 
due to the disappearance of synchronous firing. As the muscle twitch 
returned to control height following blockade by the depolarizers, anti-
dromic firing in the nerve was not' observed and the ephaptic response was 
not potentiated from that of control. 
Methoxyambenonium (? -20 ,ug) did not produce repetitive firing either 
on the muscle or the nerve confirming the results of Blaber andBowman 
(1963 a). However, in some cases the muscle twitch was slightly 
potentiated. 
B. The effect of facilitatory and deeolarizing drugs in the absence 
of nerve stimulation 
In these experiments single nerve shocks were delivered at intervals 
of 10 seconds as in the previous experiments, but discontinued shortly 
before the drug was to be administered. A typical record of muscle and 
ventral root activity in response to ambenonium is shown in figure 9. The 
resting activity of the muscle and nerve was increased considerably in this 
case in the absence of electrical stimulation. This activity is concluded 
to be a direct action of the drug at the neuromuscular junction. 
/ 
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3. 1 kg. Cat - Muscle potentials (upper trace) and antidromic nerve 
potentials recorded in the ventral root {lower trace) in the absence 
of nerve stimulation. a) At a. 2 ,ug ambenonium c. a.; b) 15 sec. 
later; c) 15 minutes later; d) 30 minutes later; e) 60 minutes later. 
Voltage calibration: 50,uV, muscle . 25 mV; time: l second. 
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Oscilloscope recordings were photographed on 35 mm. film,. and 
/ indirect stimulation was restarted and continued until it was tlme for the 
next injection. 
Neostigmine and Edrophonium 
These compounds in doses of 5 p.g (total dose} were capable of 
eliciting activity in the nerve and the muscle in the absence of electrical 
stimulation. The.response occurred 3-4 seconds after injection of these 
compounds and lasted several minutes, after which a decrease in amplitude 
of the spikes occurred and slowly faded to control levels. It appeared that 
the decrease in amplitude was more pronounced than the decrease in 
frequency of spikes as the effect of the dru~ wore off. 
The effect on the muscle was not as pronounced as that on the nerve. 
The spikes which occurred faded much faster than those of the nerve. 
At any time during direct action of the compound if an indirect 
stimulus was applied the nerve and muscle activity was potentiated ~n 
amplitude and frequency. However, it is difficult to determine if the effects 
of the drug in the junctional region were prolonged. 
Ambenonium 
This drug in doses of 2 p.g (Total dose c. a.) produced a similar 
action to that of neostigmine. There was a longer latency {15 sec.) after 
the injection of the drug before activity was noticed on the muscle and 
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nerve. When activity started it was of a higher amplitude and greater 
/ 
frequency than that observed with neostigmine. The direct effect of the 
drug on nerve and muscle potentials lasted for more than one hour before 
fading to a resting level of activity. This compound proved to be capable 
of producing the greatest magnitude of activity at the junction of any of the 
compounds studied in these ecperiments. The activity on the nerve and 
muscle could, as with neostigmine, be potentiated with indirect stimulation. 
The animals were observed to show symptoms of anticholinesterase 
poisoning after this compound, such as salivation, fasciculations throughout 
the entire animal and, in some cases, urination. 
Succinylcholine and Decamethonium . 
The direct action of these compounds on nerve and muscle action 
potentials did not seem to differ in form from the anticholinesterase 
compounds as it did after indirect stimulation. At the dose level used 
(0. 5 ,ug total) there was firing present in the nerve and muscle after a 
latent period of 3-4 seconds. 
The activity was not present at a constant level as it was with 
neostigmine or ambenonium. It appeared to be a "bursting" type of 
activity, i.e., short periods with a decrease in amplitude followed by an 
. 
increase in: amplitude period. However, the activity does not change in 
character as does the activity following orthodromic stimulation. In the 
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absence of orthodr01nic activity the nerve response is like that produced by 
the anticholinesterase compounds and it does not disappear due to any . 
blockade. At higher dose levels no activity in the nerve was observed but, 
in contrast to the fasciculations produced at the lower dose, the muscle gave 
an immediate twitch-like response accompanied by a burst of asynchronous 
muscle potentials. 
Acetylcholine 
The direct action of acetylcholine on the nerve terminal was tested 
using three methods. Intravenous injections produced no response. The 
close arterial administration of acetylcholine at doses ranging from 0. 01 to 
50 Mg c. a. produced no more than a short burst of activity in the ventral 
root. The muscle response was somewhat longer. This was true whether 
it was administered in the presence or absence of orthodromic stimulation. 
It has previously been reported that direct firing was observed 
following distant arterial injection of 100 J.1 g of acetylcholine (Masland and 
Wigton, 1940). Direct firing did result following distant arterial adminis-
tration of acetylcholine in the femoral artery at a dose of 50 pg, which is 
considerably less than that previously reported. However, this firing was 
not of the amplitude nor duration seen with the other depolarizing compounds 
~nee it was a d. a. injection the possibility existed that acetylcholine was 
hy-drolyzed before it r·eached the effector cell and that choline was actually 
,--
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stimulating the nerve. An equivalent amount of choline {38. 5 :1-1g) was 
injected and caused no observable effect in the nerve. / The muscle twitch 
increased following injection of acetylcholine and then fell to below control 
level which lasted approximately 30 minutes. {See figure 10). 
Methoxyambenonium produced no antidromic discharge when adminis-
tered alone. However, whm it was followed by one of the other facilitatory 
agents, antidromic discharges were produced following a greater number 
of orthodromic stimuli compared with the administration of the facilitatory 
agent alone. The magnitude of the muscle twitch was potentiated over that 
produced by the facilitator alone. 
The duration of the nerve terminal response was noticeably increased 
in the methoxyambenonium-edrophonium combination, lasting almost 30 
minutes, which is approximately twice what would be expected with 
edrophonium alone. 
The combination of a facilitatory drug and a depolarizing compound 
caused an increase in the magnitude of the nerve terminal response 
following orthodromic stimulation. However, with the exception of 
methoxyambenonium, this combination shortened the duration of the responsE 
when compared with that produced by either drug in the combination. This· 
was most likely due to an increase in onset of neuromuscular blockade 
produced with the combination. The block was faster in onset, increased 
. ~ 
1 
·l j 
! 
' 
FIGURE 10 
b. 
c. 
3. 3 kg. Cat - Muscle potentials (upper trace and antidromic nerve 
potentials recorded in the ventral root (lower trace) in the absence of 
nerve stimulation. a) 50 .ug d. a. acetylcholine; b) 10 sec. later; 
c) 1 minute later. Voltage: nerve 50 .uV, muscle . 25 mV; time: 
1 second. 
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in depth and duration compared to the blockade produced with the depolarizer 
alone. / 
The activity produced in the presence of orthodromic stimulation 
was greatest in magnitude and shortest in duration following the neostigmine 
decamethonium combination. The increase in magnitude was least pronounc 
following the edrophonium-succinylcholine combination. However, the 
duration of activity was longest in the methoxyambenonium-succinylcholine 
combination lasting for over 30 minutes while it was shortest following the 
administration of neostigmine-decamethonium lasting less than 5 minutes. 
It should be stated that the term "magnitude" in the context in which it 
is used in this thesis refers to both the amplitude and duration of an anti-
dromic response. 
The terms "asynchronous" and 11 synchronous" were applied following 
visual comparison of the duration of single repetitive nerve spikes in 
different antidromic response trains. 
77 
II. INTERACTION AT THE NERVE TERMINAL 
A. Combinations of the test compounds / 
When the facilitatory agents were administered in combinations with 
one another the effect was an increase in magnitude and a prolongation of 
the nerve terminal response when compared to the administration of either 
drug alone. This was true whether orthodromic stimulation was applied or 
not. (See figure 11). 
The increase in nerve terminal response was not as pronounced though 
for all combinations. ~mbenonium was, as mentioned previously, a potent 
inducer of antidromic firing. In combinations with other compounds a 
prolongation of activity was not markedly i!lcreased over ambenonium 
alone. The amplitude of the response was initially increased and this 
increase lasted for approximately 20 minutes with edrophonium, 30 minutes 
with neostigmine, and 45 minutes with methoxyambenonium, although with 
the latter compound the increased magnitude was not as great as with the 
other compounds. The duration of nerve terminal firing lasted 40-50 
minutes when ambenonium was given with another facilitatory agent which 
was approximately the same duration as when ambenonium was given alone. 
In the absence of stimulation, combinations of facilitatory and 
depolarizing compounds did not cause a shortening of either one's action. 
In this situation an increase in magnitude of response was accompanied 
by an increase in duration with, once again, the exception of methoxyam-
FIGURE 11 
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2. 6 kg. Cat - Antidromic nerve potentials recorded in the ventral 
root following a single nerve stimulus. a) Control; b) 1 .u g neo-
_stigmine c. a.; c) control; d) 5 .ug edrophonium c. a.; e) 1 .ug 
1_1eostigmine c. a. followed by edrophonium c. a. Voltage calibration: 
100 .u V; time:'lO msec. 
. •, 
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benonium (figure 12). In the absence of orthodromic stimulation the 
magnitude was the greatest and the duration longest in the ambenonium-
/ 
decamethonium combination and the magnitude least and duration shortest 
in the edrophonium-succinylcholine combination. 
Methoxyambenonium is of particular interest here because it has been 
reported to antagonize decamethonium paralysis in the cat, as well as 
tubocurarine paralysis (Karczmar, 1957). Methoxyambenonium was 
injected 5 ,ug intra-arterially 2 minutes previously to depolarizers which 
were given intravenously in doses (35 ,ug), sufficient to reduce the twitch 
tension of the tibialis anticus muscle by approximately 40%. In the presence 
of orthodromic stimulation this combination caused a lessening of the 
paralysis caused by the depolarizer alone. The antidromic firing on the 
root was increased in magnitude and more prolonged following this combina-
tion than with the depolarizer alone (figure 13). This antagonism of 
blockade ~ould agree wilh Blaber' s and Karc zmar' s ( 1967) experiments 
showing reversal of depolarizing paralysis by certain doses of methoxyam-
benonium. 
Another finding in these experiments which was particular to 
methoxyambenonium was the antagonism of the direct nerve terminal 
response to depolarizers. When given alone it has been shown that they 
produced firing in the ventral root. It was stated above that methoxyam-
FIGURE 12 
c. 
3. 4 kg. Cat - Muscle potentials (upper trace} and antidromic nerve 
potentials recorded on the ventral root (lower trace) in the absence 
of nerve stimulation. a) Control; b) 0. 5 ,ug C 10; c) 0. 5 ,ug C 10 
and 5 pg neostigmine. Voltage calibration: nerve 50 ,uV, muscle 
. 25 mV; time: 1 second. 
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4. 6 kg. Cat -Antidromic nerve potentials recorded in the ventral root 
following a single nerve stimulus. a) Control; b) 45 pg succinylcholine 
i. v.; c) 2 pg methoxyambenonium i. a.; d) 45 pg succinylcholine i. v. 
2 minutes after c.; e) 30 minutes after d. Voltage calibration: 50 J.l v; 
time calibration: 10 msec. 
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benonium in combination with depolarizers potentiates the response following 
orthodromic stimulation. However, in the absence of orthoc(r01nic stimu-
lation methoxyambenonium administered previous to a depolarizer caused 
blockade of nerve terminal firing {figure 14.). However, it will be noticed 
that the repetitive firing on the muscle was not changed with this combination. 
This block lasted for nearly an hour before backfiring could be induced by 
the depolarizer. 
Methoxyambenonium was also administered distal arterially {20 ,ug) 
previous to a dose of acetylcholine (50 ,ug} which was shown to induce 
repetitive firing in the terminal in the absence of indirect stimulation. This 
dose of methoxyambenonium caused no nerve terminal or muscle repetitive 
firing but did increase the amount of firing in amplitude, frequency and 
duration following acetylcholine. Neostigmine {100 ,ug) which also caused 
spontaneous firing distal arterially, increased the response to acetylcholine 
in the same way as methoxyambenonium. 
- B. Effect of transmitter depletors 
No substance is known to inhibit specifically choline acetylase after 
systemic administration, although larger amounts of any inhibitors of 
other enzymes may do so to some extent {Berman-Reisberg, 1957). An 
important series of compounds known to reduce acetylcholine synthesis are 
the hemicholiniums. These were synthesized by Long and frhueler in 1954. 
The most active member of this series is hemicholinium No. 3 (HC -3). 
... 
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FIGURE 14 
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. 3. 0 kg. Cat- Antidromic nerve potentials recorded in the ventral 
root in the absence of nerve stimulation. At a) 0. 5 ,ug .decamethonium 
c. a.; b) follows a; c) 5% ,ug c.a..methoxyambenonium; d) 0. 5 ,ug 
decamethonium c. a. 2 minutes after c. Voltage calibration: 
nerve 20 p. V, muscle . 25 mV; time calibration: 1 second. 
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During prolonged tetanization at 10-20/sec. of muscles treated with HC-3, 
/ 
there is a progressive and severe diminution of the miniature e. p. p. 's 
virtually to extinction and there is a parallel diminution of the e. p. p. 's 
(Elmqvist, Quastel and Thesleff, 1963). It seems likely that this action 
of HC -3 is a demonstration of a reduction in the quantal size of acetylcholine 
Nerve stimulation is required for HC -3 to effect a blockade of cholinergic 
transmission in situ and, further, there appears to be a direct relationship 
between degree of depression and frequency of stimulai:ion (Wilson and 
Long, 1959; Chang and Rand, 1960; Wong and Long, 1961). A striking 
characteristic of the transmission failure produced by HC -3 is the marked 
antagonistic ability of choline. HC -3 is be~ieved to act by combining with, 
and thereby temporarily inactivating, the choline -carrier mechanism which 
is responsible for transporting extra-cellular choline across the membranes 
of cholinergic nerve -endings to the intracellular sites of its acetylation 
(Gardiner, 1957; Macintosh, 1961; Birks and Macintosh, 1961). Thus, 
HC-3 renders the nerve terminals deficient in choline and, therefore, in 
acetylcholine. This then causes the block which is characteristically slow 
in onset and dependent on the frequency of stimulation of the nerve. 
HC -3 also has been shown to cause neuromuscular block by acting as 
a curarizing agent when applied to rat or frog muscles in vitro, decreasing 
their sensitivity to directly applied acetylcholine and also decreasing the 
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size of the m. e. p. p. 1 s without affecting their frequency or the quantal 
numbers of the e. p. p. 's produced by nerve stimulation (Martin and 
Orkand, 1961; Thies and Brooks, 1961). 
Another mechanism of action of HC -3 has been proposed recently; 
Hart and Long (1965) were unable to detect any significant differences in 
tissue levels of acetylcholine after HC-3 administration and though that 
an anti-release mechanism for the compound 3hou1d be CO)lSidered. 
< 
Other compounds have been shown to exhibit actions similar to 
those of HC -3. An extensive investigation was carried out by Bowman 
and his associates with regard to the triethyl-analogue of choline, N -triethyl-
amino ethanol (triethyl 2-hydroxyethyl-ammonium, triethylcholine, TEC::). 
TEC produces a failure of neuromuscular transmission; the rate of onset 
and degree of paralysis increases with increasing frequency of stimulation. 
The blockade by TEC is reversed by an excess of choline and TEC also 
possesses a weak curare-like action (Bowman and Rand, 1961). All 
this points to a possible mechanism of action like that of HC -3. n· 
has been shown in vitro (Burgen, Burke, and Desbarats-Schonbaum,l956) 
that TEC is readily acetylated by the enzyme, choline acetylase. The 
nerve terminal, therefore, may accept TEC in place of choline and 
liberate an inactive transmitter ("false transmitter"). However, Hemsworth 
and Morris (1964) were unable io confirrn these findings. One of the strange 
effects of TEC is that neuromuscular failure produced by TEC is often 
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preceded by an increase in the amplitude of twitch and the compound is 
thought to initially increase the output of acetylcholine (Bowrrtan, et. al., 
1962). 
In the following experiments the effects of intravenously injected 
HC -3 (I mg. /kg.) and TEC (25 mg. /kg.) during various stimulating 
frequencies were studied. Some general observations which apply to all 
stimulus frequencies can be made at the outset. TEC was observed to 
cause a slight potentiation of the muscle twitch for a short time after its 
administration; however, this was not observed to cause any activity on 
the ventral root. HC -3 did not cause an increase in twitch nor was there 
any observable antidromic firing on the nerve terminal with this compound 
alone. HC -3 did cause appreciable fall in blood pressure upon its 
administration which leveled out after 2-3 minutes. 
Choline (5 mg. /kg.) was used in many cases to antagonize TEC or 
HC -3 blockade. Choline proved a much more effective antagonist of TEC's 
activity than it did of HC-3 1 s. It did, however, antagonize HC-3 blockade 
but in some cases two doses were required to bring the muscle twitch back 
to control levels. Choline itself was never observed to cause any anti-
dromic firing. 
3:imulating 1/10 sec. 
HC -3 (1 mg. /kg.) had no effect on the drug induced firing following 
orthodromic stimulation in the case of depolarizers and facilitators. We 
would not expect acetylcholine depletion with this stimulus frequency, but 
it was necessary to test the reported curare effect of HC -3 to ~ee if it 
could antagonize nerve terminal firing. 
Stimulating 1/sec. 
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At this frequency of stimulation we would expect HC -3 and TEC to 
produce muscle block. This was the case. Depolarizers or facilitators, 
however, produced antidromic firing, resembling the control activity, 
immediately following the injection of TEC or HC -3, which in all cases 
diminished as the block became maximal. The time for this was approxi-
mately 20 minutes for TEC a~d 90 minutes for HC -3. After the adminis-
tration of choline {5 mg. /kg. i. v.) or after the effect of the HC-3 and TEG 
had worn off, control level firing was obtained. It should be stressed that, 
in some cases, as shown in figurel5 the total block of the muscle {which 
only occurred in the case of HC -3) did not completely abolish nerve 
firing. In this figure we can observe the synchronous firing of succinyl-
choline changing to asynchronous during total blockade of the muscle twitch 
by HC -3. There was no ephaptic response present during this time. In 
other cases the firing was not present during block nor could it be 
observed after a return to control twitch height. In many cases the muscle 
did not return to control twitch levels. At this frequency of stimulation 
HC -3 had other variations of response, i.e., in some cases it blocked the 
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FIGURE 15 
/ 
L 
-'· a. b. 
c. d. 
2. 9 kg. Cat -
Antidromic nerve potentials recorded in the ventral root following 
a single nerve stimulus. a) Control; b) 30 ,ug succinylcholine i. v. ; 
c) 30 Ag succinylcholine i. v. at 50% paralysis following 1 mg/kg 
hemicholinium i. v. ; d) 30 Ag succinylcholine i. v. at 95% paralysis 
following 1 mg/kg hemicholinium i. v. Voltage calibration: 100 AV; 
time calibration: 20 msec. 
appearance of antidromic firing with partie ular com pounds, and in other 
/ 
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cases it did not. The synchronous firing was not always inhibited so that 
the asynchronous was unmasked. For these reasons a higher rate of 
stimulation was used to produce a faster block with the same dosage of 
HC -3. This allowed a more constant experimentation to be carried out. 
Stimulating at 100/sec. for 150 msec. once every 10 sec. 
Under these conditions a constant series of nerve action potentials 
like those shown in figure 16 is produced. Ventral root activity is inter-
preted as a depression in the train of impulses (Blaber, 1962). The 
depression of the spikes in the train is due to extinction of the nerve action 
potentials through collision with the back firing in the nerve. Typical 
responses to close-arterial injections of neostigmine and succinylcholine 
are shown in figures 16 and 17. The depression of spikes occurred upon 
the injection of these agents prior to and immediately following an intra-
venous dose of either TEC or HC-3. However, as the time between the 
administration of the inhibitory drug and that of the test agent was increased 
the nerve terminal activity dec rea sed in a direct relationship with the block-
ade of the muscle twitch. There was no depression of spikes (i.e., no anti-
dromic firing) following c. a. injections of either anticholinesterase or 
depolarizing agents during the period of maximal blockade of TEC. and 
HC -3. Maximal blockade of muscle twitch occurred about 60 minutes after 
FIGURE 16 
/ 
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a. b. 
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I t ! I ! l t I I f I 
,• ' ' . ' 
c. 
2. 7 kg4 Cat ... Antidromic nerve potentials recorded in the ventral 
root in response to a tetanic stimulus. a) Control; b) .following 
edrophonium 5 p.g c. a. Between band c triethylcholine 25 mg/kg 
i. v. was administered. c) Following edrophonium 5 p.g c. a. at 
95% paralysis due to the triethylcholine. Voltage calibration: 
0. 5 mV; time calibration: 20 msec. 
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FIGURE 17 
/ 
a. b. 
c. 
3. 1 kg. Cat - An1idromic nerve potentials recorded in the ventral 
root in response to a tetanic stimulus. a) Control; b) following 
succinylcholine 0. 5 }.lg c. a. Between band c hemicholinium 
1 mg/kg was administered. c) Following succinylcholine 0. 5 ,ug 
c. a. at 95% paralysis due to the hemicholinium. Voltage calibra-
tion: 20 ,u V; time calibration: 20 msec. 
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the administration of HC -3 and 20 minutes after TEC. TEC and HC -3 were 
/ 
discovered to have an unreported action at this stimulation frequency 
which is important when considering the effects of drugs on the nerve 
• 
terminal. It was observed that a progressive increase in the amplitudes 
of the spikes, recorded from the ventral root, occurred after the adminis-
tration of these compounds which reached a maximal height at the time of 
greatest blockade. This, for lack of a better explanation, was interpreted as 
a hyperpolarizing action.· This phenomenon can be seen in these figures. 
Immediately following the injection of choline a return to controls 
levels of the muscle and nerve was obtained and the facilitatory and 
depolarizing agents again showed nerve terminal actions. 
In some cases the HC -3 action outlasted that of the choline and the 
musCle would return into blockade, corresponding to the twitch height 
it would have been at if no choline had been given. The antidromic activity 
was again reduced. 
C. Tubocurarine 
Small doses of tubocurarine injected close-arterially (1 ,ug at the 
height of the effect of the facilitatory drugs did not abolish the repetitive 
firing in the ventral root. Larger amounts of the blocking drug (5 ,u g 
given close-arterially} did partially antagonize the antidromic firing from 
the terminal. However, this was short lasting (20 minutes} and it was 
decided that larger intravenous doses should be tried. One hundred ,ug 
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curare administered i. v. before the administration of a facilitatory agent 
or depolarizing com pound abolished the repetitive firing in lSoth the ventral 
root and the muscle produced by these agents (figure 18). This amount of 
curare produced depression of the muscle twitch by approximately 20%. 
A further dose of a facilitatory or depolarizing compound given within 
the next 45-60 minutes did not restore the repetition. This finding 
confirms that the main blocking action of curare is post synaptic. 
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FIGURE 18 
. c. 
2. 9 kg. Cat - Muscle action potentials (upper trace) and antidromic 
nerve action potentials recorded in the ventral root (lower trace) in 
the absence of nerve stimulation. At a) decamethonium 0. 5 pg c. a. 
was injected. Tubocurarine 100 p.g i. v. was administered 2 minutes 
before b. At b) 0. 5 pg decamethonium c. a. was administered. 
c) 30 minutes after b. Voltage calibration: nerve 50 p.V, muscle 
. 25 mV; time calibration: 1 second. 
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III. MICROELEC TRODE STUDIES 
This phase of the research was carried out to test )Yhether 
~ . 
succinylcholine and decamethonium were depolarizing the nerve terminal. 
Katz (1962) concluded that m. e. p. p. frequency is controlled entirely by 
the conditions of the presynaptic membrane. Liley {1956) showed that a 
tenfold increase in frequency of them. e. p. p. could be expected from a 
15 mv. depolarization of the nerve terminal. 
In four experiments neither decamethonium or succinylcholine 
produced any readily observable change in frequency, amplitude, or rise 
time of m. e. p. p. 1 s at concentrations ranging from 1o-1 2 molar to 10-6 
molar. The frequency varied throughout the experiment but it is unlikely 
that any changes were drug induced.{See Liley, 1956). The amplitude of 
m. e. p. p. 1 s diminished as the end-plate membrane was depolarized 
{Table 1). Decamethonium depolarized the end-plate at 10-7 molar while 
succinylcholine depolarized at 5 X 10-6 molar. This shows them to be 
potent depolarizers of the end-plate when one considers that acetylcholine 
depolarizes at approximately 10-3 molar (Blaber and Christ", 1967}. It 
may be concluded that succinylcholine and decamethonium do not depolarize 
the motor nerve terminal. 
TABLE 1-A 
/ 
Effects of Succinz:lcholine on M,e•E•2•s 
Frequency 
Concentration of Membrane 
of m.e.p.~.s Amplitude Rise-time Half-decay Potential 
Succinllcholine ~Ml tsec- la tmV) b . (msec)b ~msec)b tmV} 
Control 1. 7. t 0.1 o.s t o.1 0.7 t 0.4 1.2 t 0.2 75 
1o-10 2.0 :!: 0.1 o.s t 0.1 0.7 t 0.1 1.0 t 0.2 77 
to- 9 .1.9 :!: 0.1 0.5 + 0.1 0.7 + 0.1 1.1 + o.t 78 
- -! 
·Jo-8 2.2 + 0.1* o.s :!: 0.1 0.7 :!: 0.1 1.2 t 0.2 80 
-
' 
5 X 10- 8 2.2 t 0,1* 0.4 t 0.1 o.8 :!: 0,1 1.1 t 0.1 80 
to-7 70 
TABLE 1-B 
Effects of Decamethonium on M.e•2•2•S 
.Frequency 
Concentration of Membrane 
of m.e.p.~.s Amplitude Rise-time Half-decay Potential 
Decamethonium ~M) ~sec- ) a ~mVlb ~msec) b (msec) b (mVl 
Control 2.1 t 0.1 o.8 t 0.2 0.6 t 0.1 1.2 t 0.1 68 
to-9 1.8 t 0.1 0.6 t 0,2 0.6 t 0.1 1.2 + 0.3 65 
-
to- 8 1.9 t 0.1 0.6 + 0.2 0.7 t 0.1 1.0 + 0.2 68 
- -· 
lo- 7 2.1 t 0,1 0.7 + 0.2 0.7 t o.t 1.1 t 0.2 70 
-
5 X lo- 6 53 
l 
~ a t Standard error of the mean. 
I b :!: Standard deviation. 
I 
I 
* Difference statistically significant at the 0.1% le el as compared 
to the control. 
M.e.p.p.s too small to measure accurately. 
DISCUSSION 
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I. EFFECTS OF S:NGLE DRUGS 
/ 
A. The effect of facilitatory and depolarizing drugs following 
stimulation by a single volley 
The.results of the present investigation have confirmed the results 
of Blaber and Bowman ( 1963 a) that edrophonium, neostigmine and 
ambenonium produce antidromic firing in the motor nerve following 
orthodromic stimulation. No antidromic firing was observed in the 
presence of methoxyambenonium also confirmi~g the results of Blaber 
and Bowman. 
Antidromic firing was also observed in the presence of succinyl-
choline and decamethonium following ortho?romic stimulation. However, 
the response differed from that produced by the facilitatory drugs in that 
' . 
it was more synchronous. The ephaptic response was increased in 
amplitude in some cases to more than four times the control height. As 
the muscle became paralysed the synchronous firing disappeared leaving 
only asynchronous firing which resembled very closely the antidromic 
firing produced by the facilitatory drugs. Brown and Matthews ( 1960) 
concluded from their experiments that the synchronous stimulation of all 
the muscle fibers was required to elicit the ephaptic ~espouse. Blaber 
and Bowman (1963 a), however, showed that the antidromic firing 
produced by the facilitatory drugs continued when the muscle was 
stimulated submaximally and at a time when no ephaptic response was 
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elicited. It is concluded from the present results that the synchronous 
firing is ephaptically indue ed, depolarization at the nerve terminal lowers 
/ 
the threshold to stimulation causing more terminals to be stimulated 
ephaptically and increasing the amplitude of the ephaptic response. 
Moreover, the reduced threshold to stimulation of the nerve terminal 
causes the nerve to be stimulated more than once causing the synchronous 
firing. As the muscle becomes paralyzed the action currents of the 
muscle are no longer sufficient to excite the nerve, and the asynchronous 
firing, which originated in the nerve terminal, remains. The asynchronous 
firing also disappeared when the muscle was totally paralyzed and did not 
reappear as the muscle recovered spontaneously from the blockade. 
B. The effect of facilitatory and depolarizing drugs in the absence 
of nerve stimulation 
Neostigmine and edrophonium produced firing in the nerve following a 
latent period. The response of the nerve corresponded to fasciculations 
in the muscle which have been previously reported by Randall (1950) and 
Blaber and Bowman (1959). It is possible that these two drugs may 
produce depolarization at the nerve terminal since at higher dose levels 
they are known to depolarize the motor end-plate and to directly stimulate 
the muscle (Wescoe and Riker, 1951; Nastuk and Alexander, 1954: 
Blaber and Christ, 1967). 
r 
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Ambenonium will also produce antidromic firing in the motor nerve 
in the absence of nerve stimulation, although the latent perioj is 15 sec. 
as compared to 2-3 sec. for neostigmine and edrophonium, and the firing 
lasts for more than one hour as compared to 30 minutes for neostigmine 
and edrophonium. The firing produced by ambenonium is difficult to 
explain since the drug has never been reported to have depolarizing 
properties and is a comp·.3titive blocking drug at the neuromuscular 
junction at higher dose levels {Blaber, 1960). The possibility exists 
that since this drug is a powerful anticholinesterase and, in contrast to the 
other facilitatory drugs used, could inhibit cholinesterase at the dose 
levels used {Blaber, 1963). Therefore, acetylcholine preserved at the 
junction could be producing these effects. This may account for the 
longer latency before the antidromic firing commences. A similar 
explanation was used by Blaber and Bowman {1963 a) to account for the 
prolonged antidromic firing, following orthodromic stimulation, in the 
presence of ambenonium. 
Succinylcholine and decamethonium also produced antidromic 
firing in the nerve, in the absence of stimulation, following a latent 
period. The effects were produced by low doses {0. 5 p.g c. a.) and the 
response in the nerve preceded those in the muscle. At higher dose 
levels of the depolarizing drugs, there was no activity in the nerve but 
an imm~diate response was produced in the muscle, this being, 
/ 
presumably, the response to depolarization of the end-plate. 
It can be concluded,therefore, that the nerve terminal is more 
sensitive to depolarization than the end-plate and that the muscle 
fasciculations produced by low doses of the depolarizing drugs are a 
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result of depolarization of the nerve terminal. At higher dose levels the 
nerve is no longer stimulated, possibly the intense depolarization 
producing a blocking action_ resembling cathodal block. At this dose 
level the end-plate is depolarized producing an immediate muscle 
response. 
It must also be concluded that at dose levels which block trans-
mission not only is the neuromuscular junction blocked postsynaptically 
but also presynaptically, this presynaptic block being also responsible 
for the disappearance of the antidromic firing following orthodromic 
stimulation when the muscle is totally paralyzed. 
Acetylcholine produced very little response when administered 
close-arterially in doses of 0. 01-50 p.g, confirming the results of 
Riker (1966) who found that doses of 100 p.g/kg. c. a., i.e. , 300 p.g in an 
average 3 kg. cat were required to produce antidromic firing. Masland 
and Wigton (1940) observed antidromic firing in response to 100 p.g 
acetylcholine given distant arterially. This was confirmed in the p :-.:esent 
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experiments where it was found that a dose of 50 ,ug 
/ 
would produce firing if given distant .arterially. Sine e it was difficult to 
evaluate the results of these experiments the site of action being unknown, 
they were not elaborated upon, but an equivalent dose of choline did not 
produce a response and, therefore, the firing was due to the acetylcholine . 
• 
II. EFFECT OF DRUG COMBINATIONS 
A. Effect of the combined administration of the facilitatory and 
depolarizing drugs following stimulation by a single volley 
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The combined administration of any two of the facilitatory drugs 
augmented the antidromic firing observed following an orthodromic 
stimulus. However, due to the intense response produced by ambenonium 
alone the augmentation was not marked. The combination of either 
edrophonium or neostigmine with methoxyambenonium markedly augmented 
the antidromic firing both with regard to amplitude and duration of the 
drug response even though methoxyambenonium by itself produced no 
response. The combination of a facilitatory drug and a depolarizing drug 
augmented the amplitude but shortened the time of drug response of the 
depolarizing drug given alone with the exception of methoxyambenonium 
which augmented both the amplitude and duration of action. 
Combination of a depolarizing drug with either edrophonium, neostig-
mine or ambenonium augmented the muscle twitch in the facilitat.ory phase 
and deepened the block compared to a control response, confirming the 
result of Blaber and Karczmar (1967) with neostigmine. The increased 
muscle block was probably responsible for the decreased duration of the 
nerve response. The effect of a combination of methoxyambenonium and a 
depolarizer, in the present results, produced antidromic discharges follow-
ing a greater number of orthodromic stimuli when compared with the 
administration of the depolarizing agent alone. Karc zmar ( 1957) and Blaber 
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and Karczmar (1967} described the 11 reversaP 1 response produced by a 
combination of methoxyambenonium and a depolarizing drug. In this regard 
the usual response produced by a depolarizing drug of facilita{ion followed 
by blockade was converted to a response consisting of only facilitation, 
which was augmented and prolonged over the control response. 
B. The effect of a combination of the facilitatory and depolarizing 
drugs in the absence of nerve stimulation 
Any two facil~tatory drugs produced an augmented and prolonged re-
sponse when compared to either alone. The same was true for edrophonium, 
neostigmine and ambenonium when combined with a depolarizing drug. 
However, when methoxyambenonium, which by itself produced no response, 
was combined with a depolarizing drug, the response of the depolarizing 
drug was blocked. 
When methoxyambenonium or neostigmine was administered distant 
.arterially previous to a dose of acetylcholine both drugs augmented the 
response to acetylcholine, thus showing the possibility of a different site of 
action of the acetylcholine. 
The fact that methoxyambenonium will augment the antidromic firing 
following an orthodromic stimulus in the presence of a depolarizing drug 
and yet will block the response in the absence of nerve stimulation leads 
to the conclusion that the antidromic firing following a stimulus and the 
antidromic firing in the absence of stimulation originate at different sites. 
105 
c. The effect of tubocurarine on the response of the facilitatory and 
depolarizing drugs in the motor nerve / 
Tubocurarine administered i. v. before the facilitatory or depolarizing 
drugs abolished the antidromic firing produced either following an ortho-
dromic stimulus or in the absence of stimulation. The dose of tubocurarine 
necessary to do this depressed the twitch approximately 20o/o at the peak 
blockade. However, the antidromic response was abolished for approxi-
mately one hour, whereas the slight tubocurarine blockade lasted only five 
minutes. 
Tubocurarine will therefore abolish antidromic firing at both sites on 
the nerve terminal at a time when the muscle is not blocked. 
D. The effect of facilitatory and depolarizing drugs when acetyl-
choline is depleted from the nerve terminal 
Hemicholinium (SJ.ueler, 1955; Mcintosh, 1961) and triethylcholine 
(Bowman and Rand, 1961) were used to deplete the motor nerve terminal 
of acetylcholine. Neither HC -3 or TEC changed the response of the 
facilitatory or depolarizing drugs when the nerve was stimulated once every 
ten seconds. With these conditions there is no depletion of transmitter. 
When the nerve was stimulated at a rate of one per second inconsistent 
results were obtained. Control responses were obtained to both the 
facilitatory and depolarizing drugs immediately following the administration 
of HC -3 or TEC. However, when the muscle was blocked by the HC -3 or 
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TEC in some cases the facilitatory drugs produced a control res:Ponse, in 
/ 
some cases with a diminished response and in some cases with no response. 
The depolarizing drugs sometimes produced a control response, some-
times the synchronous firing was blocked leaving the asynchronous firing 
and sometimes the response was completely blocked. When tetanic 
stimulation of the nerve was used the response to the facilitatory and 
depolarizing drugs were not diminished immediately following the 
administration of HC-3 or TEC; however, at maximal block the response 
to both the facilitatory and depolarizing drugs was abolished. 
It was observed that at the time of maximal block by HC -3 or TEC 
the amplitude of the spikes as recorded from the ventral root was 
increased. It is difficult to explain this result as hyperpolarization since 
the response was recorded from the ventral root presumably. devoid of its 
blood supply. Choline, the specific antagonist of HC-3 and TEC reversed 
the effect on the spikes and the response to the facilitatory and depolarizing 
drugs returned. 
No conclusion can be drawn for these results concerning the 
possibility of acetylcholine mediating in the response of the facilitatory 
drugs since the response to the depolarizing drugs was also blocked, the 
mechanism being unknown. 
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III. THE EFFECT OF DEPOLARIZING DRUGS ON MINIATURE END-
/ 
PLATE POTENTIAL FREQUENCY 
Them. e. p. p. frequency is a measure of the membrane potential of the 
motor nerve terminal. The cat tenuissimus has been used which responds 
in the same way to drugs as the anterior tibialis muscle (Maclagan, 1962). 
The m. e. p. p. frequency was not changed by concentrations of 
succinylcholine or decamethonium ranging from l0- 12 M to 10-6 M. 
Decamethonium depolarized_ the end-plate at 5 X 10-6 M and succinylcholine 
at 10-7 M. 
It may be concluded from these experiments that neither decametho-
nium or succinylcholine depolarize the motor nerve terminal and that the 
antidromic firing produced in the absence of nerve stimulation must 
originate from a site on the motor nerve more central than the nerve 
terminal. 
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IV • G E N E R A L D I SC U SSI 0 N 
/ 
Werner (1961) comparing ephaptic responses with drug induced anti-
dromic firing concluded that the loop time for stimulation of a ventral 
rootlet to recording the response in a ventral root filament was shorter 
than expected if conduction along the entire loop was to take place. He 
concluded that the stimulus from the muscle action currents stimulated the 
intramuscular axons rather than the unmylinated terminals. He also 
concluded that a focal stimulus in the muscle also stimulated the intra-
muse ular axon. Hubbard, S::hmidt, and Yokota ( 1965) stimulated the 
motor nerve terminal through a microelectrode and concluded that their 
point of stimulus was not the unmyelinated terminal and reasoned that 
their technique would not permit stimulation of a distant site. They 
decided, therefore, that the first node was the point of stimulation. 
For the purpose of this discussion we shall assume that the point 
of stimulation is the first node and that the ephaptic response originates at 
this point. 
It follows that the decrease in threshold to ephaptic stimulation 
occurs at the first node and, therefore, this is the point at which the 
depolarizing drugs act, both to augment the ephaptic response and to 
produce antidromic firing in the absence of nerve stimulation. The present 
results have also shown that the depolarizing drugs do not increase 
r 
1 09 
m. e. p. p. 's frequency and, therefore, do not depolarize the unmyelinated 
terminal. Methoxyambenonium blocks the antidromic firing/produced by 
the depolarizing drugs in the absence of stimulation at the first node. This 
is probably due to the curare -like action of methoxyambenonium (Blaber, 
1960) since tubocurarine also blocked this action. The facilitatory drugs 
must also produce antidromic firing in the absence of nerve stimulation 
at the first node since they do not depolarize the unmyelinated terminal 
(Blaber and Christ, 196 7). 
It has been concluded that the antidromic firing produced by the 
facilitatory drugs following an orthodromic stimulus originates in the 
unmyelinated terminal (Werner, 1960 a & b, 1961; Hubbard and S:hmidt, 
1963; Blaber and Bowman, 1963 a & b). It is reasoned that the drugs 
augment and prolong the negative after potential following an orthodromic 
stimulus which produces a repetitive stimulation of the first node. The 
depolarizing drugs either produce a similar action on the unmyelinated 
terminal in addition to the depolarization at the first node or depolarization 
of the first node reduces the threshold sufficiently for an unchanged 
negative after potential to stimulate it. The latter explanation is unlikely 
since methoxyambenonium would prevent depolarization of the first node 
while augmenting the antidromic firing following an orthodromic stimulus. 
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If the first node is a point of stimulation at the neuromuscular junction 
for the ephaptic response, the evidence in this thesis supports the 
/ 
following proposals: 
1. Facilitatory drugs do not appear to act by depolarization of the 
terminals or the first node. 
2. The response of the facilitatory drugs at the motor nerve terminal does 
not appear to be mediated by acetylcholine since acetylcholine is 
ineffective in producing these responses. 
3. Depolarizing drugs appear to lower the threshold to stimulation at 
the first node and may also augment the negative after potential in 
the unmyelinated terminal. 
r 
/ 
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